🔗

Mappings

MONDO

MONDO:0015436 ring chromosome 20

MONDO:0015436 is the ring chromosome 20 concept, the chromosomal epilepsy syndrome modeled by this entry.

👪

Inheritance

1

Sporadic, usually postzygotic HP:0003745

The ring almost always arises de novo. In the common mosaic form it forms after fertilization, which is why a normal cell line persists alongside the ring line and why the ring fraction differs between tissues and between patients. The rarer non-mosaic form, which does carry terminal deletions, is consistent with an origin in meiosis. Familial recurrence is the exception rather than the rule, but it is not absent: four families are on record in which a mosaic mother transmitted the ring to her children, also in a mosaic state. In every one of those families the children carried a higher proportion of ring-bearing cells than the mother did, and that higher ratio went with earlier seizure onset. The counselling position is therefore that recurrence risk is low but not zero, that transmission when it occurs is maternal and mosaic-to-mosaic, and that an affected child may be more severely affected than the parent who transmitted the ring.

Sporadic

Show evidence (4 references)

PMID:20972251 SUPPORT Human Clinical

"The mosaic nature of these rings suggests a postzygotic origin with formation of the ring by fusion of the telomeric regions with no apparent loss of subtelomeric or telomeric DNA."

Establishes the postzygotic origin of the common mosaic form, which is what makes the syndrome sporadic rather than transmitted.

PMID:20972251 SUPPORT Human Clinical

"The non-mosaic nature of these rings is consistent with a meiotic origin."

Establishes the contrasting meiotic origin of the rarer non-mosaic form, which is why this entry models two distinct upstream nodes.

PMID:33363513 SUPPORT Other

"However, four familial cases have been reported thus far. In all the families a mosaic mother transmitted r(20) to the offspring in a mosaic state"

Documents the exception to sporadic occurrence, which is counselling relevant and is why the block no longer says familial recurrence is not a feature.

+ 1 more reference

?

Discussions and Knowledge Gaps

4

Why are patients with mosaic ring chromosome 20 disproportionately female, when the ring arises postzygotically and involves an autosome?

KNOWLEDGE GAP OPEN r20_unexplained_female_excess

Attached to

pathophysiology#Postzygotic Mosaic Ring Without Detectable Deletion pathophysiology#Telomere-Telomere Fusion Forming Ring Chromosome 20

Chromosome 20 is an autosome and the mosaic ring forms after fertilization, so there is no obvious route by which sex should matter. Yet the sex ratio is consistently skewed: a systematic review of 192 patients found only 40 percent male, and the skew has been reported specifically in the mosaic group rather than the non-mosaic one. Several explanations are available and none has been tested. It could be ascertainment, if girls with unexplained cognitive and behavioural decline are investigated differently from boys. It could be survival, if male embryos tolerate the ring and its ongoing instability less well, which would predict an excess of male losses rather than a female excess among survivors. It could reflect a genuine sex-dependent difference in tolerance of aneuploid or ring-bearing lineages during early development, which is testable. Or it could be a real but modest effect inflated by publication bias across a literature made almost entirely of case reports and small series. Which of these is right matters for whether the ratio is telling us something about ring biology or only about how the syndrome gets found.

Proposed experiments

Sex ratio in a diagnostically unbiased ascertainment stream

exp_r20_unbiased_ascertainment_sex_ratio

Determine the sex ratio among ring 20 cases found by routine karyotyping of all children meeting a pre-specified clinical trigger, such as drug-resistant focal epilepsy with recurrent confusional episodes, rather than among published cases. Prospective registry ascertainment with a fixed testing rule removes the referral asymmetry that the case literature cannot exclude.

Decision criterion

A sex ratio near parity under a fixed testing rule would identify the published excess as ascertainment bias. A persistent female excess would make it a biological finding needing a mechanism.

Show evidence (1 reference)

PMID:42468067 SUPPORT Human Clinical

"Seventy-one studies were included (192 patients), 40.4% (n = 67/166) were male."

Quantifies the sex skew across the pooled published literature, which is the observation this gap is about. It also shows the base is published cases, which is precisely why ascertainment cannot be excluded.

If most ring 20 patients lose no genetic material, what does the ring actually do to make cortex epileptogenic, and why has every concrete candidate mechanism tested so far failed?

CONTROVERSY UNDER DISCUSSION r20_mechanism_without_deletion

Attached to

pathophysiology#Ring Ratio-Dependent Cortical Network Dysfunction pathophysiology#Mitotic Ring Instability and Dynamic Mosaicism pathophysiology#Postzygotic Mosaic Ring Without Detectable Deletion

This is the central unsolved problem of the syndrome and the reason the mechanism graph carries an explicitly empty hub node. Two candidate accounts have been put to the test and both came back negative. The first was gene dosage: distal chromosome 20q carries plausible epilepsy genes, notably the nicotinic receptor subunit CHRNA4 implicated in sleep-related frontal epilepsy, so deletion at the fusion point looked promising. It cannot be the general answer, because the mosaic majority have no detectable deletion in either cell line, and a review of the accumulated evidence concluded that candidate gene deletion is not responsible. The second was a position effect: circularizing a chromosome moves formerly telomeric regions into a new context and might silence or derepress genes near the join. A transcriptome study of a patient cohort looked specifically for that and found no altered expression in peritelomeric or other chromosome 20 regions, concluding that peritelomeric altered transcription is not the likely pathogenic mechanism. A third candidate has since been tested and also failed. If circularizing the chromosome silences subtelomeric genes through telomeric heterochromatin spreading, that silencing should show up as altered methylation; a genome-wide methylation screen in r(20) patients found no shared epigenetic signature anywhere, and specifically none at CHRNA4 or KCNQ2. The authors note the array covers subtelomeric regions poorly, so this is a strong negative rather than a conclusive one. There is also a cleaner argument against dosage than the absence of deletions: people who carry terminal deletions of chromosome 20 on an ordinary linear chromosome do not develop this epilepsy. Losing the material is not sufficient; the ring is doing something the deletion does not. What remains are less tractable hypotheses. Dynamic mosaicism, in which ring instability continuously generates secondary aberrations and ring-loss cells, is the accepted explanation for the growth failure of ring syndromes generally but has not been shown to drive the ring 20 epilepsy, and it has a problem of its own: only 12 of 35 evaluated patients had secondary aberrations above a five percent threshold, so r(20) may simply not be unstable enough for the mechanism to bear the weight. A further constraint on any generic ring-based account is that ring chromosome 2 and ring chromosome 4 patients do not develop epilepsy at all, so whatever the ring does, it does it in a chromosome-specific way. Genome-wide chromosomal instability affecting expression of genes not on chromosome 20 is raised by the same transcriptome study, which found candidate differences across many genes rather than a localized signal. Nuclear architecture is a third possibility that has barely been tested, since a ring occupies a different territory and has different lamina contacts than a rod. There is also a real methodological obstacle underlying all of this: the accessible tissue is blood, the diseased tissue is brain, and mosaicism means the two may differ in ring content, so a negative result in blood does not settle the question for cortex.

Proposed experiments

Ring content and expression in brain versus blood from the same individuals

exp_r20_brain_versus_blood_ring_content

Single-cell karyotype-informed sequencing and transcriptome profiling of postmortem or surgically obtained cortical tissue alongside matched blood from ring 20 donors, comparing ring fraction and gene expression between the two tissues.

Decision criterion

A substantially higher cortical than blood ring fraction, or a cortical expression signature absent from blood, would show that blood-based negative studies were underpowered by tissue choice rather than wrong in principle. Matching ring fractions and expression would strengthen the case that the mechanism is not transcriptional at all.

Nuclear architecture profiling of ring versus rod chromosome 20

exp_r20_nuclear_architecture_profiling

Chromosome conformation capture and lamina-association mapping in patient-derived neurons carrying the ring, comparing the ring-bearing and normal cell lines from the same mosaic individual, which provides an internally controlled comparison.

Decision criterion

Reproducible differences in chromosome 20 compartment or lamina association between the ring-bearing and normal lines of the same patient would support a nuclear architecture mechanism. Indistinguishable architecture would push the field toward instability-based accounts.

Show evidence (10 references)

PMID:22406087 REFUTE Other

"While the underlying etiology of the phenotype is still not understood, evidence is accumulating which suggests the deletion of candidate genes on chromosome 20 is not responsible."

Refutes the candidate-gene deletion hypothesis, which is why no genetic section names CHRNA4 or any other chromosome 20 gene as causal.

PMID:33363513 REFUTE Human Clinical

"Enrichment analysis of SEM did not show any suggestive or highly shared epigenetic signature on either chromosome 20 or other chromosomes. No differences in methylation levels were found in the two main candidate genes CHRNA4 and KCNQ2."

Refutes the epigenetic-silencing hypothesis, the third concrete candidate mechanism, using a genome-wide methylation screen designed to test it.

PMID:33363513 SUPPORT Other

"However, given the relatively low coverage of subtelomeric regions on the 450K array, a refinement of the analysis by a custom-targeted methylation assay may be necessary to exclude epigenetic silencing of the genes located in the p and q subtelomeric regions in r(20) patients."

The authors' own limitation on that negative result. Marked PARTIAL because it means the silencing hypothesis is disfavoured rather than excluded, and it names the assay that would settle it.

+ 7 more references

Is the long-lasting rhythmic slow-wave pattern of ring 20 genuinely nonconvulsive status epilepticus, or an encephalopathic rhythm that is not itself seizure activity, and should it therefore be treated aggressively?

CONTROVERSY OPEN r20_is_the_rhythmic_pattern_ictal

Attached to

pathophysiology#Prolonged Nonconvulsive Status Epilepticus pathophysiology#Frontally Predominant Cortical Hyperexcitability

The pattern is called ictal by convention, but several features sit awkwardly with that reading. It can persist for days, far beyond what status epilepticus usually means. Its spike content is sparse, and a direct comparison found that ring 20 patients in nonconvulsive status had a less prominent spike component than patients in nonconvulsive status without the ring. Patients often remain partly responsive during it, sometimes answering questions, and in one reported pair daily activities were minimally affected while the discharges continued. Most telling, oral medication reduced the overt focal seizures by more than three quarters in those patients while leaving the electrical pattern entirely unchanged, a dissociation that would be surprising if the two shared a generator. The authors of that report state plainly that the mechanism of the continuous rhythmic waves may be unrelated to epilepsy. The opposing evidence is also real: the pattern accompanies confusional states that patients and families recognize as events, it is closely associated with cognitive decline in longitudinal series, and the current consensus treats it as status and recommends aggressive detection. The stake is direct and clinical. If it is status, prolonged episodes justify escalating treatment and possibly anaesthesia; if it is an encephalopathic rhythm, that escalation carries risk with no benefit, and the target of treatment should be the overt seizures instead.

Proposed experiments

Metabolic and cerebral blood flow imaging during the rhythmic pattern

exp_r20_metabolic_imaging_during_rhythmic_pattern

Ictal-interictal comparison using perfusion or metabolic imaging acquired during a prolonged rhythmic slow-wave episode and again in the same patient at baseline, testing whether the pattern is accompanied by the regional hypermetabolism and hyperperfusion that characterize genuine ictal activity.

Decision criterion

Focal or regional hypermetabolism time-locked to the pattern would support a true ictal process and justify aggressive treatment. Absent or reduced metabolic change would support the encephalopathic-rhythm reading and argue against escalation.

Time-locked cognitive testing during and between rhythmic episodes

exp_r20_cognitive_timelock_during_pattern

Standardized within-patient cognitive testing performed during the rhythmic pattern and during matched pattern-free periods, quantifying whether measurable performance falls while the pattern is running.

Decision criterion

A reproducible performance drop during the pattern would establish it as functionally disabling regardless of its label. Preserved performance would show the pattern is electrographic in a strong sense and would shift the treatment target to the overt seizures.

Show evidence (5 references)

PMID:16128150 SUPPORT Human Clinical

"The electroclinical correlations in our cases raise the possibility that the mechanism of continuous rhythmic waves in this syndrome may be unrelated to epilepsy."

States the sceptical position explicitly.

PMID:16128150 SUPPORT Human Clinical

"Despite the continuous discharges, the patients had relatively subtle clinical episodes of seizures, during which they were sometimes responsive to verbal stimuli."

Documents the preserved responsiveness that is hard to reconcile with ongoing status epilepticus.

PMID:16128150 SUPPORT Human Clinical

"Oral AEDs decreased more than 75% of the overt CPS episodes in both patients at 22 and 26 months of follow-up but had no effect on the natural history of electrical NCSE."

Documents the pharmacological dissociation between the overt seizures and the electrical pattern.

+ 2 more references

Is the intellectual disability of ring 20 caused by the epilepsy, making this a true developmental and epileptic encephalopathy, or is it a parallel consequence of carrying the ring that would occur regardless of seizure control?

CONTROVERSY OPEN r20_encephalopathy_versus_parallel_effect

Attached to

pathophysiology#Cognitive Decline and Behavioural Disturbance pathophysiology#Prolonged Nonconvulsive Status Epilepticus

The encephalopathy reading rests on a genuinely striking observation: children develop normally and only then lose ground, with intellectual disability manifesting after seizure onset. It is reinforced by the finding that earlier seizure onset predicts worse cognitive outcome. But the correlation is confounded, because a higher ring ratio predicts both earlier seizure onset and worse cognition, so seizure timing may be a marker of ring burden rather than the cause of the cognitive outcome. Two further observations cut against the pure encephalopathy account. Behavioural disturbance has been reported to begin before the first seizure in a substantial minority, which no seizure-driven mechanism can explain. And adolescent-onset patients had a milder developmental course with no cognitive decline despite having both dyscognitive seizures and nonconvulsive status, suggesting the vulnerable window matters more than seizure burden. The question is not academic: if the epilepsy drives the cognitive outcome, then aggressive early seizure control is cognitively protective and worth its side effects, whereas if cognition tracks ring burden independently, that aggressive approach buys less than it appears to and families deserve to know that.

Proposed experiments

Ring-ratio-adjusted modeling of cognitive outcome in a multicentre cohort

exp_r20_ring_ratio_adjusted_cognitive_modeling

Pooled multicentre longitudinal cohort with ring ratio, age at seizure onset, seizure and status burden, and serial standardized cognitive testing, modeling cognitive trajectory with ring ratio and seizure burden entered as separate predictors rather than examined pairwise.

Decision criterion

An independent effect of seizure and status burden after adjustment for ring ratio would support the encephalopathy model. Cognitive outcome explained by ring ratio alone, with seizure burden adding nothing, would support the parallel-effect model.

Prospective developmental assessment of ring carriers before seizure onset

exp_r20_prospective_preseizure_developmental_assessment

Systematic developmental and behavioural assessment of individuals found to carry a ring 20 before epilepsy has begun, including relatives and incidental findings, establishing whether measurable deficits precede the first seizure.

Decision criterion

Detectable pre-seizure developmental or behavioural deviation would show part of the phenotype is seizure-independent. Genuinely normal pre-seizure development across a series would strengthen the encephalopathy model.

Show evidence (4 references)

PMID:33363513 SUPPORT Other

"intellectual disability manifesting after seizure onset in otherwise normally developing children"

The core observation supporting the encephalopathy reading.

PMID:22424860 REFUTE Human Clinical

"There were three patients out of six with behavioral disturbances before the onset of seizures."

Refutes the claim that the whole neurobehavioural phenotype follows the seizures, since half of this series showed disturbance beforehand.

PMID:27816898 SUPPORT Human Clinical

"The r(20) ratio and severity of cognitive impairment appear to be directly related to each other and inversely correlated with the age at epilepsy onset."

Documents the three-way correlation that makes seizure onset age and ring ratio impossible to separate without adjusted modeling, which is the confound this discussion turns on.

+ 1 more reference

⚙

Pathophysiology

10

Telomere-Telomere Fusion Forming Ring Chromosome 20

The short and long arms of chromosome 20 join end to end, converting a normally rod-shaped chromosome into a closed circle. The defining and counterintuitive feature is that this can happen with no loss of coding sequence: patients are symptomatic even when nothing has been deleted. That single fact is what rules out a straightforward gene-dosage account and forces the rest of this graph to be modeled around an unresolved step.

telomere maintenance GO:0000723 ⚠ ABNORMAL

Downstream

Postzygotic Mosaic Ring Without Detectable Deletion

Meiotic Non-Mosaic Ring With Terminal Deletion

Show evidence (2 references)

PMID:42096279 SUPPORT Other

"The disease is caused by fusion of the long and short arms of chromosome 20. Patients are symptomatic even if there is no loss of genetic material."

States both the physical lesion and the crucial observation that it causes disease without deleting anything.

PMID:28127864 SUPPORT Human Clinical

"A complete ring chromosome without loss of genetic material results from fusion of subtelomeric regions or telomere-telomere fusion."

Describes the physical mechanism of complete ring formation. Marked PARTIAL because the case reported is a ring chromosome 4, so it establishes the general cytogenetic principle rather than a chromosome 20 observation.

Postzygotic Mosaic Ring Without Detectable Deletion

In the majority of patients the ring is present in only a proportion of cells, with two structurally normal chromosome 20s in the rest, and neither cell line shows any detectable deletion or duplication. This is the group that defines the mechanistic problem, and it is also the group that a chromosomal microarray will call normal, because there is no copy number change to find. The proportion of ring-bearing cells, the ring ratio, behaves like a dose: a higher ratio goes with earlier seizure onset and worse cognition.

chromosome segregation GO:0007059 ⚠ ABNORMAL

Downstream

Mitotic Ring Instability and Dynamic Mosaicism

Ring Ratio-Dependent Cortical Network Dysfunction

Show evidence (3 references)

PMID:22406087 SUPPORT Other

"However, in the majority of cases the ring is present in only a proportion of cells, with two normal 20's in the remaining cells (mosaicism), and in these cases, no deletions of chromosome 20 have been observed."

Establishes that the common form is mosaic and carries no deletion, which is the premise of this node.

PMID:20972251 SUPPORT Human Clinical

"Group 1 (N=21) was mosaic for the r(20) and a normal cell line with no detectable deletions or duplications of chromosome 20 in either cell line."

Quantifies the mosaic group in a molecularly characterized cohort and confirms the absence of copy number change by array analysis.

PMID:22406087 SUPPORT Other

"The age of onset of seizures correlates with the percentage of cells with the ring in mosaic patients."

Supports the dose-like behaviour of the ring ratio that this node asserts and that the downstream hub node depends on.

Meiotic Non-Mosaic Ring With Terminal Deletion

A minority of patients carry the ring in every cell examined, and in these the ring is almost always accompanied by deletion of the terminal segments of one or both arms near the fusion point. This group behaves worse: seizure onset is several years earlier and comorbidities are more extensive. The contrast is informative rather than incidental, because it shows the syndrome is molecularly heterogeneous, and it means findings from one group should not be assumed to hold in the other.

Downstream

Ring Ratio-Dependent Cortical Network Dysfunction

Show evidence (3 references)

PMID:20972251 SUPPORT Human Clinical

"Group 2 (N=7) had non-mosaic ring chromosomes with a deletion at one or both ends of the chromosome, near the ring fusion point."

Defines the non-mosaic group and its associated terminal deletions.

PMID:20972251 SUPPORT Human Clinical

"The age of onset of seizures was significantly lower in the non-mosaic patients (group 2, median age of onset 2.1 years) than in the mosaic patients (group 1, median age of onset 6.0 years)."

Quantifies the phenotypic difference between the two structural groups, which is why they are modeled as separate nodes.

PMID:22406087 SUPPORT Other

"In some patients, the ring (20) is found in all cells analyzed and in these cases, the ring is almost always accompanied by deletions of 20pter and/or 20qter."

Independent confirmation that the non-mosaic form carries terminal deletions.

Mitotic Ring Instability and Dynamic Mosaicism

A circular chromosome is mechanically awkward at mitosis. Sister chromatid exchange within a ring produces interlocked or double-sized rings that segregate badly, so ring-bearing lineages continuously generate secondary aberrations and cells that have lost the ring entirely. This continuous reshuffling is called dynamic mosaicism, and it is the accepted explanation for the growth failure of the general ring syndrome. Whether it is also what drives the ring 20 epilepsy is proposed rather than established, which is why the arrow from here into the hub node is one of the open questions recorded in the discussions block.

chromosome segregation GO:0007059 ⚠ ABNORMAL

Downstream

Ring Ratio-Dependent Cortical Network Dysfunction

Show evidence (2 references)

PMID:28127864 SUPPORT Human Clinical

"Ring syndrome is thought to be caused by "dynamic mosaicism" due to ring instability."

States the dynamic mosaicism hypothesis. Marked PARTIAL because it is offered for the general ring syndrome in a ring chromosome 4 case, not demonstrated for the ring 20 epilepsy phenotype.

PMID:33207017 SUPPORT Human Clinical

"there may be genome-wide chromosomal instability affecting gene expression"

Raises genome-wide instability as a confounder and candidate mechanism in ring 20 specifically. Marked PARTIAL because the authors raise it as an interpretive caution rather than measuring it.

Ring Ratio-Dependent Cortical Network Dysfunction

The unresolved step. Something about carrying the ring makes cortex epileptogenic, in proportion to how many cells carry it, without any lesion visible on imaging and without a neurological deficit on examination before seizures start. Two concrete candidate mechanisms have been tested and disfavoured: deletion of candidate genes on chromosome 20, which cannot apply to the mosaic majority who delete nothing, and altered expression of genes near the fusion point, which a patient transcriptome study looked for and did not find. This node exists so that the graph does not paper over that gap; it is a placeholder for a real biological step whose content is unknown, not a claim.

frontal lobe UBERON:0016525

Downstream

Frontally Predominant Cortical Hyperexcitability

Show evidence (3 references)

PMID:22406087 SUPPORT Other

"While the underlying etiology of the phenotype is still not understood, evidence is accumulating which suggests the deletion of candidate genes on chromosome 20 is not responsible."

States both halves of what this node encodes: that the step is unexplained, and that the obvious gene-deletion explanation has been disfavoured.

PMID:33207017 SUPPORT Human Clinical

"the mechanism by which individuals with complete ring chromosomes develop seizures and other phenotypic abnormalities is not understood"

Confirms independently and more recently that the step modeled by this node has no established molecular content.

PMID:9217679 SUPPORT Human Clinical

"Neurological examination results were normal, and neuroimaging studies often failed to disclose a brain lesion."

Establishes that the dysfunction is not accompanied by a structural lesion, which is why it is modeled as a network-level abnormality rather than as a malformation.

Frontally Predominant Cortical Hyperexcitability

Whatever the upstream cause, the network output is a hyperexcitable, hypersynchronous cortex with a frontal accent. The electroencephalographic signature is not the brief spike-wave of the generalized epilepsies but long-lasting bilateral high-voltage slow waves with only occasional spike components, often rhythmic theta with frontal predominance. The relative poverty of the spike component, alongside seizures that are clinically subtle relative to how dramatic the tracing looks, is a recurring observation and the seed of a genuine dispute about whether this pattern is ictal at all.

pyramidal neuron CL:0000598

regulation of postsynaptic membrane potential GO:0060078 ⚠ ABNORMAL

Downstream

Nigrostriatal Seizure-Termination Failure

Drug-Resistant Focal Epilepsy

Show evidence (2 references)

PMID:9217679 SUPPORT Human Clinical

"an ictal EEG pattern of long-lasting bilateral paroxysmal high-voltage slow waves with occasional spikes"

Describes the characteristic electrographic pattern that defines this node.

PMID:22424860 SUPPORT Human Clinical

"Electroencephalogram recordings showed rhythmic theta waves with frontal predominance and non-convulsive status epilepticus (NCSE)."

Supports the frontal predominance asserted in this node's name.

Nigrostriatal Seizure-Termination Failure

The most distinctive thing about r(20) seizures is not that they start but that they will not stop, and this node is the reason to think that is a separate defect rather than just severe ictogenesis. Basal ganglia circuits, and striatal dopaminergic transmission in particular, are thought to interrupt seizures rather than generate them. In r(20), fluorodopa uptake is significantly reduced in both putamen and caudate, and functional imaging during an actual seizure shows the substantia nigra and striatum lighting up alongside frontal cortex. Notably the dopaminergic reduction does not track the ring ratio, so it behaves like a property of the syndrome rather than a dose effect. A seizure-stopping system that works poorly is exactly what a syndrome defined by days-long nonconvulsive status looks like from the inside.

substantia nigra UBERON:0002038 striatum UBERON:0002435

Downstream

Prolonged Nonconvulsive Status Epilepticus

Show evidence (3 references)

PMID:15249613 SUPPORT Human Clinical

"Striatal dopamine is modulated in r(20) epilepsy; dysfunction of this neurotransmission may impair the mechanisms that interrupt seizures."

States the seizure-termination hypothesis that this node encodes, from the study that measured it.

PMID:15249613 SUPPORT Human Clinical

"This reduction was equal for both nuclei and was not correlated to the percentage of cells with r(20)."

Shows the dopaminergic deficit is independent of ring ratio, which is why it is modeled as its own node rather than as another consequence of ring burden.

PMID:22738216 SUPPORT Human Clinical

"We observed ictal BOLD increments in a cortical-subcortical network involving substantia nigrastriatum and frontal cortex."

Functional imaging during an actual seizure showing the nigrostriatal system engaged, which is the direct observation behind this node. Single patient, so the node is supported rather than established.

Prolonged Nonconvulsive Status Epilepticus

The most characteristic clinical event: a long confusional state, sometimes lasting days, during which awareness fluctuates and the patient may still respond to speech. It is easy to mistake for a behavioural change or a bad day, which is why the consensus advice is to have a low threshold for video-electroencephalography whenever behaviour or alertness shifts. It recurs, it is refractory to the drugs that do control the overt focal seizures, and it is the main driver of the encephalopathic decline.

Downstream

Cognitive Decline and Behavioural Disturbance

Show evidence (3 references)

PMID:9217679 SUPPORT Human Clinical

"frequent seizures consisting of a prolonged confusional state, with or without additional motor seizures"

Defines the cardinal clinical event modeled by this node.

PMID:16128150 SUPPORT Human Clinical

"Twenty-four-hour video/EEG telemetry recorded during the NCSE showed fluctuating consciousness between overt unresponsiveness and normal awareness."

Documents the fluctuating awareness that makes the episodes hard to recognize clinically.

PMID:27816898 SUPPORT Human Clinical

"often evolving into epileptic encephalopathy associated with non-convulsive status epilepticus (11 patients)"

Links the status epilepticus to the encephalopathic outcome that this node feeds.

Drug-Resistant Focal Epilepsy

Alongside the status episodes, patients have recurrent focal seizures: dyscognitive seizures, focal motor seizures often arising from sleep, and characteristically terrifying hallucinations at onset in childhood. Later in the course focal seizures with motor and autonomic features and eyelid myoclonia appear. Drug resistance is close to the rule, and the current consensus is that families should be told at diagnosis that the seizures are likely to be lifelong.

Downstream

Cognitive Decline and Behavioural Disturbance

Show evidence (3 references)

PMID:27816898 SUPPORT Human Clinical

"When seizure onset occurred in childhood (21 patients), terrifying hallucinations associated with focal motor seizures, often sleep-related (8 patients), or dyscognitive seizures (13 patients), were prominent features"

Enumerates the focal seizure semiology this node asserts, in the largest single series.

PMID:22424860 SUPPORT Human Clinical

"All patients presented with pharmacoresistant frontal lobe complex partial seizures."

Supports both the focal frontal character and the drug resistance.

PMID:42096279 SUPPORT Other

"if patients are diagnosed with epilepsy, they and their families should be counseled that seizures are likely to be drug-resistant and life-long"

States the expert consensus on prognosis, which is the practical content of drug resistance here.

Cognitive Decline and Behavioural Disturbance

Children who were developing normally lose ground after seizures begin, accumulating intellectual disability and behavioural problems, and the severity tracks both the ring ratio and how early the seizures started. That pattern is what earns the syndrome its classification as a developmental and epileptic encephalopathy. The classification is not unchallenged: behavioural disturbance has been reported to begin before the first seizure in some patients, which would make part of the cognitive phenotype a parallel effect of the ring rather than a consequence of the epilepsy. That dispute is recorded in the discussions block.

Show evidence (2 references)

PMID:33363513 SUPPORT Other

"r(20) syndrome is characterized by a recognizable epileptic phenotype with typical EEG pattern, intellectual disability manifesting after seizure onset in otherwise normally developing children, and behavioral changes."

States the post-seizure-onset timing of the cognitive decline that underpins the encephalopathy framing.

PMID:27816898 SUPPORT Human Clinical

"The r(20) ratio and severity of cognitive impairment appear to be directly related to each other and inversely correlated with the age at epilepsy onset."

Quantifies the relationship between ring burden, seizure onset age, and cognitive outcome that this node depends on.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

9

Nervous System 4

EEG abnormality with long-lasting rhythmic slow waves HP:0002353

Show evidence (2 references)

PMID:9217679 SUPPORT Human Clinical

"an ictal EEG pattern of long-lasting bilateral paroxysmal high-voltage slow waves with occasional spikes"

Describes the characteristic pattern.

PMID:16128150 SUPPORT Human Clinical

"The EEG consisted of long-lasting generalized rhythmic 3-5 Hz sharp or slow waves with a few spikes, lasting several days."

Quantifies the frequency band and the extraordinary duration.

Intellectual disability HP:0001249

Course: PROGRESSIVE

Show evidence (2 references)

PMID:33363513 SUPPORT Other

"intellectual disability manifesting after seizure onset in otherwise normally developing children"

States the characteristic timing of the cognitive impairment.

PMID:27816898 SUPPORT Human Clinical

"We found statistically significant correlations between age at epilepsy onset and cognitive level."

Supports the relationship between seizure onset age and cognitive outcome.

Behavioural disturbance Atypical behavior HP:0000708

Show evidence (2 references)

PMID:22424860 SUPPORT Human Clinical

"There were three patients out of six with behavioral disturbances before the onset of seizures."

Documents behavioural disturbance preceding seizure onset, the observation that motivates the encephalopathy controversy in the discussions block.

PMID:22406087 SUPPORT Other

"Ring Chromosome 20 syndrome is a rare chromosomal disorder characterized by refractory epilepsy, with seizures in wakefulness and sleep, behavioral problems and mild to severe cognitive impairment."

Establishes behavioural problems as a defining component of the syndrome.

Hallucinations at seizure onset HP:0000738

Show evidence (1 reference)

PMID:27816898 SUPPORT Human Clinical

"terrifying hallucinations associated with focal motor seizures, often sleep-related (8 patients), or dyscognitive seizures (13 patients), were prominent features"

Documents ictal hallucinations as a prominent feature of childhood-onset cases.

Other 5

Drug-resistant focal epilepsy FREQUENT Focal impaired awareness seizure HP:0002384

Course: PROGRESSIVE

Show evidence (4 references)

PMID:42468067 SUPPORT Human Clinical

"Focal seizures with impaired consciousness were most common (n = 94/187, 50.3%)."

94 of 187 pooled patients, which is 50.3 percent and falls in the FREQUENT band, and establishes this as the commonest single seizure type.

PMID:42468067 SUPPORT Human Clinical

"The median number of ASMs tried was 4 (2,7); most patients (80%, n = 92/115) were drug-resistant."

Quantifies the drug resistance asserted in this phenotype's name across the pooled literature.

PMID:22424860 SUPPORT Human Clinical

"All patients presented with pharmacoresistant frontal lobe complex partial seizures."

Documents focal impaired-awareness seizures with drug resistance in every patient of the series.

+ 1 more reference

Nonconvulsive status epilepticus VERY_FREQUENT Non-convulsive status epilepticus without coma HP:0032671

Temporal: RECURRENT

Show evidence (3 references)

PMID:42468067 SUPPORT Human Clinical

"Information on non-convulsive status epilepticus (NCSE) was available in 143 cases; 126 had experienced NCSE (88%)."

126 of 143 patients across 71 studies, which is 88 percent and falls in the VERY_FREQUENT band. The denominator is all r(20) patients with the information available rather than a status-selected subgroup, so the estimate is not circular. This systematic review supersedes the smaller single-series estimate for the purpose of the band.

PMID:27816898 SUPPORT Human Clinical

"often evolving into epileptic encephalopathy associated with non-convulsive status epilepticus (11 patients)"

Eleven of 25 in a single series, which is lower than the pooled figure. Marked PARTIAL because a single centre series is a weaker basis for the band than the systematic review, and it is retained to show the spread between reports rather than to set the band.

PMID:42096279 SUPPORT Other

"as there is a high incidence of non-convulsive status epilepticus (NCSE), there should be a low threshold for video-EEG monitoring if patients have a change in behavior or level of consciousness"

Corroborates the high frequency and states its clinical consequence for monitoring.

Ictal fear FREQUENT Focal emotional seizure with fear/anxiety/panic HP:0032739

Show evidence (2 references)

PMID:42468067 SUPPORT Human Clinical

"Seventy-eight patient reports reported the presence of ictal fear, which was present in 56 cases (72%)."

56 of 78 patients for whom the feature was reported, which is 72 percent and falls in the FREQUENT band. The denominator is restricted to reports that addressed ictal fear at all, which is stated here because that is a narrower base than the full 192-patient cohort.

PMID:42468067 SUPPORT Human Clinical

"Ring chromosome 20 is characterized by childhood-onset drug-resistant epilepsy, predominantly focal with ictal fear and NCSE."

States ictal fear as one of the three defining features of the epilepsy phenotype.

Focal motor seizure HP:0011153

Show evidence (1 reference)

PMID:27816898 SUPPORT Human Clinical

"In the long-term, progressive stabilization of drug resistant epilepsy associated with non-convulsive status epilepticus, focal seizures with motor and autonomic features, and eyelid myoclonia were noticed."

Documents focal motor seizures in the long-term course of the syndrome.

Eyelid myoclonia seizure HP:0032678

Show evidence (1 reference)

PMID:27816898 SUPPORT Human Clinical

"In the long-term, progressive stabilization of drug resistant epilepsy associated with non-convulsive status epilepticus, focal seizures with motor and autonomic features, and eyelid myoclonia were noticed."

Documents eyelid myoclonia in the long-term seizure repertoire.

💊

Medical Actions

7

Oral antiseizure medication

Action: Pharmacotherapy NCIT:C15986

Agent: valproic acid CHEBI:39867 lamotrigine CHEBI:6367

First-line treatment is an oral antiseizure medication, but expectations should be set low. Notably, drugs can substantially reduce the overt focal seizures while leaving the electrographic status pattern untouched, a dissociation that is clinically important and is also one of the arguments in the dispute over whether that pattern is really ictal.

Mechanism Target:

INHIBITS Frontally Predominant Cortical Hyperexcitability

Show evidence (3 references)

PMID:42096279 SUPPORT Other

"initial epilepsy treatment should be with an oral anti-seizure medication"

States the consensus first-line recommendation, which is deliberately agent-agnostic.

PMID:33363513 SUPPORT Other

"In our experience, valproic acid and lamotrigine, often in combination, are generally the most effective antiepileptic drugs (AEDs) for treating seizures in r(20)"

Names the two agents recorded in therapeutic_agent. Marked PARTIAL because it is explicitly expert experience rather than trial evidence, which is the standard of evidence available for drug choice in this syndrome.

PMID:16128150 SUPPORT Human Clinical

"Oral AEDs decreased more than 75% of the overt CPS episodes in both patients at 22 and 26 months of follow-up but had no effect on the natural history of electrical NCSE."

Documents the partial and selective response that this treatment record describes. Marked PARTIAL because it is a two-patient observation and shows benefit for one seizure type only.

Home rescue medication for prolonged seizures

Action: Pharmacotherapy NCIT:C15986

Because prolonged seizures and nonconvulsive status are expected rather than exceptional, the consensus is to supply a rescue medication for use at home rather than relying on emergency presentation each time.

Mechanism Target:

INHIBITS Prolonged Nonconvulsive Status Epilepticus

Show evidence (1 reference)

PMID:42096279 SUPPORT Other

"home rescue medication should be considered given the risk for prolonged seizures and NCSE"

States the consensus recommendation and its rationale.

Ketogenic diet

Action: Ketogenic Diet NCIT:C173168

A non-pharmacological option offered when medications fail. It is recommended on the strength of expert consensus and small reports rather than controlled data, a limitation the consensus statement is explicit about.

Mechanism Target:

INHIBITS Frontally Predominant Cortical Hyperexcitability

Show evidence (1 reference)

PMID:42096279 SUPPORT Other

"for patients with drug-resistant epilepsy, ketogenic diet, vagus nerve stimulation, or deep brain stimulation could all be considered"

Names the ketogenic diet as a consensus option for drug-resistant cases. Marked PARTIAL because the same review states the evidence base is weak.

Vagus nerve stimulation

Action: vagus nerve stimulation Ontology label: Therapeutic Procedure NCIT:C49236

Implanted neurostimulation offered for drug-resistant seizures. As with the other second-line options, the recommendation rests on consensus and case experience, and it should be offered with the caveat that its efficacy in this syndrome specifically is described in the literature as controversial rather than established.

Mechanism Target:

INHIBITS Frontally Predominant Cortical Hyperexcitability

Show evidence (2 references)

PMID:42096279 SUPPORT Other

"for patients with drug-resistant epilepsy, ketogenic diet, vagus nerve stimulation, or deep brain stimulation could all be considered"

Names vagus nerve stimulation as a consensus option. Marked PARTIAL because no controlled evidence in this syndrome is cited. NCIT has no specific vagus nerve stimulation clinical-action term, so the generic Therapeutic Procedure term is used with a specific preferred_term.

PMID:33363513 SUPPORT Other

"the efficacy of vagal nerve stimulation is controversial"

Qualifies the consensus recommendation. Marked PARTIAL because it reports disagreement in the literature rather than a negative result, but it is the reason this record does not read as an established option.

Deep brain stimulation

Action: Deep Brain Stimulation NCIT:C21024

Deep brain stimulation is listed alongside vagus nerve stimulation as an option for drug-resistant seizures, and is of particular interest here because the epilepsy has no resectable focus, ruling out the surgical route that helps other drug-resistant focal epilepsies.

Mechanism Target:

INHIBITS Frontally Predominant Cortical Hyperexcitability

Show evidence (1 reference)

PMID:42096279 SUPPORT Other

"for patients with drug-resistant epilepsy, ketogenic diet, vagus nerve stimulation, or deep brain stimulation could all be considered"

Names deep brain stimulation as a consensus option. Marked PARTIAL for the same reason as the other second-line recommendations.

Multidisciplinary allied health support

Action: Supportive Care NCIT:C15747

Because the disability is cognitive and behavioural as much as it is seizure-related, the consensus is that care should be delivered by a team including speech, occupational, physical, and psychological therapy rather than by an epileptologist alone. Caregiver burnout is explicitly named as something to screen for.

Show evidence (2 references)

PMID:42096279 SUPPORT Other

"The care team should be multidisciplinary and include at least an epileptologist and allied health specialists (e.g., speech therapist, occupational therapist, physiotherapist, psychologist)"

States the consensus recommendation on care organization.

PMID:42096279 SUPPORT Other

"caregiver burnout and stress should be screened for and supports provided"

Supports the caregiver component of the recommendation.

Genetic counselling

Action: Genetic Counseling NCIT:C15240

Referral for genetic counselling is recommended for all patients and families. The counselling content is unusual for a chromosomal disorder, since the ring is nearly always de novo and postzygotic and the ring fraction rather than any deleted gene is what predicts severity.

Show evidence (1 reference)

PMID:42096279 SUPPORT Other

"patients and families should be referred for genetic counseling"

States the consensus recommendation.

🔬

Diagnosis

2

Karyotype with adequate cell counts

The diagnostic test, and a rare instance in modern practice where the older technology is the correct one. Because most patients are mosaic and carry no copy number change, a chromosomal microarray returns normal. Enough metaphase cells must be scored to detect a low ring fraction and to estimate the ring ratio, which is itself prognostically informative.

Karyotyping NCIT:C16768

Results: A ring chromosome 20 replacing one normal chromosome 20, typically in a fraction of cells, reported with the proportion of ring-bearing metaphases.

Show evidence (2 references)

PMID:22406087 SUPPORT Other

"Cytogenetic analysis, rather than chromosomal microarray analysis is recommended for diagnosis of this syndrome, as the mosaic cases do not have copy number alterations and are therefore not identified by array-based analysis."

States the diagnostic recommendation and the reason microarray fails.

PMID:25957205 SUPPORT Other

"we emphasize the importance of early G-banding chromosomal analysis when patients present with unexplainable severe seizures and repetitive NCSE, even in the absence of any dysmorphic features suggestive of a chromosomal disorder"

States the clinical trigger for ordering the karyotype, which is the practical diagnostic message of this record.

Video-electroencephalography during behavioural change

Prolonged video-electroencephalography is how nonconvulsive status is caught, and the threshold for ordering it should be low, because the clinical presentation is a change in behaviour or alertness rather than anything that looks like a seizure.

Electroencephalography NCIT:C38054

Results: Long-lasting bilateral high-voltage rhythmic slow waves at roughly 3 to 5 hertz with sparse spike components, sometimes persisting for days, with fluctuating clinical responsiveness.

Show evidence (2 references)

PMID:42096279 SUPPORT Other

"as there is a high incidence of non-convulsive status epilepticus (NCSE), there should be a low threshold for video-EEG monitoring if patients have a change in behavior or level of consciousness"

States the consensus indication for the test.

PMID:16128150 SUPPORT Human Clinical

"The EEG consisted of long-lasting generalized rhythmic 3-5 Hz sharp or slow waves with a few spikes, lasting several days."

Provides the electrographic findings reported in the results field.

📈

Progression

3

Seizure onset in a normally developing child

Age: Early childhood to adolescence

Onset is typically around school age in mosaic patients and several years earlier in the non-mosaic group, with a higher ring ratio predicting earlier onset. Development is normal beforehand, and there is usually neither dysmorphism nor a brain lesion, which is why the diagnosis is often delayed for years.

Show evidence (2 references)

PMID:20972251 SUPPORT Human Clinical

"The age of onset of seizures was significantly lower in the non-mosaic patients (group 2, median age of onset 2.1 years) than in the mosaic patients (group 1, median age of onset 6.0 years)."

Provides the onset ages for both structural groups.

PMID:22406087 SUPPORT Other

"Facial dysmorphism or other congenital malformations are rarely reported making it difficult to diagnose the syndrome based on clinical findings alone."

Supports the diagnostic delay described in this phase.

Evolution to epileptic encephalopathy with recurrent status

Age: Childhood into adult life

Childhood-onset cases commonly evolve into an epileptic encephalopathy with recurrent nonconvulsive status epilepticus and cognitive decline. Onset in adolescence carries a milder course with dyscognitive seizures and status episodes but without cognitive decline, so age at onset is the main prognostic variable.

Show evidence (2 references)

PMID:27816898 SUPPORT Human Clinical

"Epilepsy onset in adolescence (3 patients) was accompanied by a milder developmental course, dyscognitive seizures and non-convulsive status epilepticus, and no cognitive decline."

Documents the milder adolescent-onset trajectory that contrasts with the childhood-onset encephalopathy.

PMID:27816898 SUPPORT Human Clinical

"In ring(20) syndrome, epilepsy has an age dependent course and a worse outcome when age at seizure onset is earlier."

States the age-dependence of outcome that defines this phase.

Long-term persistence with rare remission

Age: Adulthood

Epilepsy continues through adult life and stabilizes rather than remits. Seizure freedom of more than five years was reached by only three of 25 patients in the largest series, all of them older, so remission is possible but should not be expected.

Show evidence (2 references)

PMID:27816898 SUPPORT Human Clinical

"Only three older patients became seizure free (>5 years)"

Quantifies how rarely long-term seizure freedom is achieved.

PMID:22424860 SUPPORT Human Clinical

"The ring chromosome 20 syndrome is characterized by childhood-onset refractory epilepsy continuing throughout adult life, mental disability, and behavioral disturbances which can originate before seizure onset."

Supports persistence of the epilepsy into adult life.

📊

Prevalence

1

Published cases worldwide

Cases In Literature Ultra Rare

No population-based prevalence estimate exists. About 200 children and adults had been reported in the literature as of 2020, roughly five decades after the first case; the 2012 count of more than 100 is retained alongside it to show the trajectory. The count is almost certainly an undercount, because the mosaic majority is invisible to chromosomal microarray and the syndrome carries no dysmorphic signature to prompt a karyotype.

Show evidence (3 references)

PMID:33363513 SUPPORT Other

"about 200 pediatric and adult individuals with r(20) syndrome have been reported in the literature"

The current published case count, from the 2020 review, superseding the 2012 figure below.

PMID:22406087 SUPPORT Other

"More than 100 cases have been published since the initial report in 1972."

Gives the published case count that this record reports.

PMID:22406087 SUPPORT Other

"Cytogenetic analysis, rather than chromosomal microarray analysis is recommended for diagnosis of this syndrome, as the mosaic cases do not have copy number alterations and are therefore not identified by array-based analysis."

Supports the ascertainment argument in the notes, that the diagnostic pathway systematically misses mosaic cases.

🔀

Differential Diagnoses

5

Conditions with similar clinical presentations that must be differentiated from Ring Chromosome 20 Syndrome:

Lennox-Gastaut Syndrome MONDO:0016532

Overlapping Features The commonest misdiagnosis, because both present as drug-resistant childhood-onset epilepsy with cognitive decline and frequent nonconvulsive status. The route out is the karyotype, not the clinical picture.

Distinguishing Features

Slow spike-wave at 1.5 to 2.5 hertz and generalized paroxysmal fast activity, rather than long-lasting rhythmic slow waves with sparse spikes.
Tonic seizures in sleep are a defining feature and are not characteristic of ring 20.
Frequently follows an identifiable structural or genetic cause; ring 20 has neither a lesion nor a causal gene.

Show evidence (1 reference)

PMID:33363513 SUPPORT Other

"The Authors report that the differential diagnosis might be challenging especially with: (1) Frontal Lobe Seizures; (2) Rolandic Epilepsy treated with sodium channel blockers (NCSE during wakefulness); and (3) Lennox-Gastaut syndrome (LGS)."

Names Lennox-Gastaut syndrome explicitly as one of the three hardest differentials for this syndrome, rather than merely establishing that differentials exist.

Ring Chromosome 14 Syndrome Not Yet Curated MONDO:0014708

Overlapping Features The nearest structural analogue: another ring chromosome syndrome with drug-resistant epilepsy, intellectual disability, behavioural change, frequent status, and the same correlation between ring ratio and severity. It is the natural control for any theory of why rings cause epilepsy, since whatever explains r(20) has to explain why r(14) differs and why r(2) and r(4) produce no epilepsy at all.

Distinguishing Features

Seizures usually begin in the first months or years of life rather than at school age.
A distinctive facial appearance is present, whereas ring 20 characteristically has none.
Ocular manifestations occur that have never been reported in ring 20.

Show evidence (2 references)

PMID:33363513 SUPPORT Other

"Status epilepticus is frequent, but seizures usually start in the first months/years of life, unlike in r(20) syndrome. Moreover, individuals with r(14) usually present with a distinctive facial appearance (epicanthic folds, down-slanting palpebral fissures, flat nasal bridge, upturned nares,..."

Supports all three distinguishing features directly: the earlier onset, the facial appearance, and the ocular findings absent from ring 20.

PMID:33363513 SUPPORT Other

"However, even if patients with different ring chromosomes such as r(14) or r(17) manifest epilepsy, their seizures differ from those of r(20) patients"

Establishes that the epilepsies of the two ring syndromes are distinguishable, which is also a constraint on any generic ring mechanism.

Phelan-McDermid Syndrome MONDO:0011652

Overlapping Features Another chromosomal disorder that pairs mild dysmorphism with intellectual disability, psychiatric symptoms, and seizures activated in sleep, so the clinical gestalt overlaps. The discriminator is the course of the epilepsy rather than its appearance at any one moment.

Distinguishing Features

Epilepsy follows a benign course, whereas ring 20 seizures are usually drug-resistant.
Caused by 22q13.3 deletion, which chromosomal microarray detects and which ring 20 mosaicism does not resemble.
Interictal abnormalities are multifocal over frontal-central and frontal-temporal regions rather than the long rhythmic slow-wave pattern of ring 20.

Show evidence (1 reference)

PMID:33363513 SUPPORT Other

"Although the typical EEG abnormalities seen in patients with Phelan-McDermid syndrome consist of multifocal paroxysmal anomalies that are prevalent over the frontal-central and frontal-temporal regions and are activated during sleep, epilepsy shows a benign course in these patients, unlike r(20)..."

Supports both the electrographic distinction and the decisive one, which is that the epilepsy is benign here and drug-resistant in ring 20.

Epilepsy with Myoclonic Atonic Seizures MONDO:0014633

Overlapping Features Another childhood epileptic encephalopathy that enters the differential when a previously normal child develops drug-resistant seizures with cognitive regression and episodes of nonconvulsive status.

Distinguishing Features

Myoclonic-atonic drop attacks are the defining seizure type and are not typical of ring 20.
Generalized rather than frontal focal semiology.
Often remits, whereas ring 20 epilepsy persists into adult life.

Show evidence (1 reference)

PMID:33363513 SUPPORT Other

"Despite the distinctive phenotype, many patients still lack a diagnosis-especially in the genomic era-and the pathomechanisms of ring formation are poorly understood."

Supports the claim that ring 20 is routinely missed and therefore confused with other childhood epileptic encephalopathies. Marked PARTIAL because it does not name this specific alternative diagnosis.

{ }

Source YAML

click to show

name: Ring Chromosome 20 Syndrome
creation_date: "2026-08-05T00:00:00Z"
category: Genetic
description: >-
  Ring chromosome 20 syndrome is a rare chromosomal epilepsy syndrome in which
  the two ends of chromosome 20 fuse into a circle, usually in only a fraction
  of cells. It is unusual and mechanistically interesting because most patients
  lose no genetic material at all in the process, yet develop a severe,
  drug-resistant childhood-onset epilepsy dominated by prolonged confusional
  episodes that carry a distinctive long-lasting rhythmic slow-wave pattern on
  the electroencephalogram. Children typically develop normally until seizures
  begin, then decline cognitively and behaviourally. There is usually no
  dysmorphism, no brain lesion on imaging, and no abnormality on chromosomal
  microarray, so the diagnosis is missed unless someone orders an old-fashioned
  karyotype. How a ring that deletes nothing produces epilepsy is genuinely
  unresolved, and the two leading candidate explanations, loss of nearby genes
  and altered expression of genes near the fusion point, have each been tested
  and found wanting.
parents:
  - Epilepsy
  - Neurological Disease
synonyms:
  - r(20) syndrome
  - ring 20 syndrome
  - ring chromosome 20
  - ring (20) chromosome epilepsy syndrome
disease_term:
  preferred_term: ring chromosome 20
  term:
    id: MONDO:0015436
    label: ring chromosome 20
mappings:
  mondo_mappings:
    - term:
        id: MONDO:0015436
        label: ring chromosome 20
      mapping_predicate: skos:exactMatch
      mapping_source: MONDO
      mapping_justification: >-
        MONDO:0015436 is the ring chromosome 20 concept, the chromosomal
        epilepsy syndrome modeled by this entry.
references:
  - reference: PMID:22406087
    title: Ring chromosome 20.
  - reference: PMID:33363513
    title: >-
      Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
      Overlapping Phenotypes.
  - reference: PMID:42096279
    title: >-
      Management of ring chromosome 20 syndrome: Narrative review and consensus
      recommendations.
notes: >-
  Scope note on the mechanism graph. This entry deliberately carries a node whose
  content is an acknowledged unknown. In most patients no coding material is lost,
  so there is no causal gene to name, and the graph runs from the ring itself to
  a hub node representing cortical network dysfunction whose molecular basis has
  not been established. Two specific candidate explanations have been actively
  tested and disfavoured, deletion of candidate genes on chromosome 20 and
  altered peritelomeric gene expression, and both are recorded with REFUTE
  evidence in the discussions block rather than being quietly dropped. Modeling
  the gap explicitly is preferable to inventing a plausible molecular chain that
  the literature does not support.

  No genetic section. Because the syndrome has no established causal gene, and
  because typing a refuted candidate as SUSCEPTIBILITY or CAUSATIVE would
  misrepresent the evidence, this entry has no genetic block. The chromosomal
  lesion is modeled in pathophysiology, and the candidate-gene question lives in
  the discussions block where the refuting evidence can be typed as such.

  Sourcing note. The entry was drafted from the primary literature and the
  consensus management review, then cross-checked against a deep-research report
  generated with the claude_code provider, committed here as
  research/Ring_Chromosome_20_Syndrome-deep-research-claude_code.md. The
  cross-check added one genuinely new mechanism, the nigrostriatal
  seizure-termination arm, which is what distinguishes this syndrome from a
  generic drug-resistant focal epilepsy and which the first draft missed
  entirely. It also replaced several single-series frequency estimates with a
  192-patient systematic review, and supplied the unexplained female excess now
  recorded as a knowledge gap. Two of its suggestions were declined: no OMIM
  identifier is cited because none exists, and the macrocephaly in the MONDO
  definition is not curated as a phenotype because the primary literature does not
  support it.

  Module conformance note. Two nodes conform to
  epilepsy_excitation_inhibition_imbalance, at the hyperexcitability and
  recurrent-seizure nodes. The entry does not claim conformance to the module's
  ion-channel trigger node, since the upstream lesion here is chromosomal and its
  route to altered excitability is exactly what is unknown. The module's
  Excitation-Inhibition Imbalance node is skipped for a related but distinct
  reason: conforming to it would assert that the network abnormality is an
  imbalance between excitation and inhibition, and nothing in the r(20) literature
  establishes which side of that balance is disturbed, or that the framing applies
  at all. What has actually been measured is a rhythmic slow-wave pattern with
  sparse spikes and a nigrostriatal seizure-termination deficit, and neither is an
  excitation-inhibition claim.
inheritance:
  - name: Sporadic, usually postzygotic
    description: >-
      The ring almost always arises de novo. In the common mosaic form it forms
      after fertilization, which is why a normal cell line persists alongside the
      ring line and why the ring fraction differs between tissues and between
      patients. The rarer non-mosaic form, which does carry terminal deletions,
      is consistent with an origin in meiosis. Familial recurrence is the
      exception rather than the rule, but it is not absent: four families are on
      record in which a mosaic mother transmitted the ring to her children, also
      in a mosaic state. In every one of those families the children carried a
      higher proportion of ring-bearing cells than the mother did, and that higher
      ratio went with earlier seizure onset. The counselling position is therefore
      that recurrence risk is low but not zero, that transmission when it occurs is
      maternal and mosaic-to-mosaic, and that an affected child may be more
      severely affected than the parent who transmitted the ring.
    inheritance_term:
      preferred_term: Sporadic
      term:
        id: HP:0003745
        label: Sporadic
    evidence:
      - reference: PMID:20972251
        reference_title: >-
          Molecular analysis of ring chromosome 20 syndrome reveals two distinct
          groups of patients.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The mosaic nature of these rings suggests a postzygotic origin with
          formation of the ring by fusion of the telomeric regions with no
          apparent loss of subtelomeric or telomeric DNA.
        explanation: >-
          Establishes the postzygotic origin of the common mosaic form, which is
          what makes the syndrome sporadic rather than transmitted.
      - reference: PMID:20972251
        reference_title: >-
          Molecular analysis of ring chromosome 20 syndrome reveals two distinct
          groups of patients.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The non-mosaic nature of these rings is consistent with a meiotic
          origin.
        explanation: >-
          Establishes the contrasting meiotic origin of the rarer non-mosaic form,
          which is why this entry models two distinct upstream nodes.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          However, four familial cases have been reported thus far. In all the
          families a mosaic mother transmitted r(20) to the offspring in a mosaic
          state
        explanation: >-
          Documents the exception to sporadic occurrence, which is counselling
          relevant and is why the block no longer says familial recurrence is not a
          feature.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          In all the familial cases, the percentage of cells containing the ring
          was higher in the offspring compared to the mothers and correlated with
          an earlier epilepsy onset
        explanation: >-
          Supports the anticipation-like pattern across the transmitting families,
          which is the specific thing a counselled family needs to know.
pathophysiology:
  - name: Telomere-Telomere Fusion Forming Ring Chromosome 20
    biological_scale: MOLECULAR
    description: >-
      The short and long arms of chromosome 20 join end to end, converting a
      normally rod-shaped chromosome into a closed circle. The defining and
      counterintuitive feature is that this can happen with no loss of coding
      sequence: patients are symptomatic even when nothing has been deleted. That
      single fact is what rules out a straightforward gene-dosage account and
      forces the rest of this graph to be modeled around an unresolved step.
    biological_processes:
      - preferred_term: telomere maintenance
        term:
          id: GO:0000723
          label: telomere maintenance
        modifier: ABNORMAL
    downstream:
      - target: Postzygotic Mosaic Ring Without Detectable Deletion
      - target: Meiotic Non-Mosaic Ring With Terminal Deletion
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          The disease is caused by fusion of the long and short arms of
          chromosome 20. Patients are symptomatic even if there is no loss of
          genetic material.
        explanation: >-
          States both the physical lesion and the crucial observation that it
          causes disease without deleting anything.
      - reference: PMID:28127864
        reference_title: >-
          Continuing role for classical cytogenetics: Case report of a boy with
          ring syndrome caused by complete ring chromosome 4 and review of
          literature.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          A complete ring chromosome without loss of genetic material results
          from fusion of subtelomeric regions or telomere-telomere fusion.
        explanation: >-
          Describes the physical mechanism of complete ring formation. Marked
          PARTIAL because the case reported is a ring chromosome 4, so it
          establishes the general cytogenetic principle rather than a chromosome
          20 observation.
  - name: Postzygotic Mosaic Ring Without Detectable Deletion
    biological_scale: CELLULAR
    description: >-
      In the majority of patients the ring is present in only a proportion of
      cells, with two structurally normal chromosome 20s in the rest, and neither
      cell line shows any detectable deletion or duplication. This is the group
      that defines the mechanistic problem, and it is also the group that a
      chromosomal microarray will call normal, because there is no copy number
      change to find. The proportion of ring-bearing cells, the ring ratio,
      behaves like a dose: a higher ratio goes with earlier seizure onset and
      worse cognition.
    biological_processes:
      - preferred_term: chromosome segregation
        term:
          id: GO:0007059
          label: chromosome segregation
        modifier: ABNORMAL
    downstream:
      - target: Mitotic Ring Instability and Dynamic Mosaicism
      - target: Ring Ratio-Dependent Cortical Network Dysfunction
    evidence:
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          However, in the majority of cases the ring is present in only a
          proportion of cells, with two normal 20's in the remaining cells
          (mosaicism), and in these cases, no deletions of chromosome 20 have been
          observed.
        explanation: >-
          Establishes that the common form is mosaic and carries no deletion,
          which is the premise of this node.
      - reference: PMID:20972251
        reference_title: >-
          Molecular analysis of ring chromosome 20 syndrome reveals two distinct
          groups of patients.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Group 1 (N=21) was mosaic for the r(20) and a normal cell line with no
          detectable deletions or duplications of chromosome 20 in either cell
          line.
        explanation: >-
          Quantifies the mosaic group in a molecularly characterized cohort and
          confirms the absence of copy number change by array analysis.
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          The age of onset of seizures correlates with the percentage of cells
          with the ring in mosaic patients.
        explanation: >-
          Supports the dose-like behaviour of the ring ratio that this node
          asserts and that the downstream hub node depends on.
  - name: Meiotic Non-Mosaic Ring With Terminal Deletion
    biological_scale: CELLULAR
    description: >-
      A minority of patients carry the ring in every cell examined, and in these
      the ring is almost always accompanied by deletion of the terminal segments
      of one or both arms near the fusion point. This group behaves worse: seizure
      onset is several years earlier and comorbidities are more extensive. The
      contrast is informative rather than incidental, because it shows the
      syndrome is molecularly heterogeneous, and it means findings from one group
      should not be assumed to hold in the other.
    downstream:
      - target: Ring Ratio-Dependent Cortical Network Dysfunction
    evidence:
      - reference: PMID:20972251
        reference_title: >-
          Molecular analysis of ring chromosome 20 syndrome reveals two distinct
          groups of patients.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Group 2 (N=7) had non-mosaic ring chromosomes with a deletion at one or
          both ends of the chromosome, near the ring fusion point.
        explanation: >-
          Defines the non-mosaic group and its associated terminal deletions.
      - reference: PMID:20972251
        reference_title: >-
          Molecular analysis of ring chromosome 20 syndrome reveals two distinct
          groups of patients.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The age of onset of seizures was significantly lower in the non-mosaic
          patients (group 2, median age of onset 2.1 years) than in the mosaic
          patients (group 1, median age of onset 6.0 years).
        explanation: >-
          Quantifies the phenotypic difference between the two structural groups,
          which is why they are modeled as separate nodes.
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          In some patients, the ring (20) is found in all cells analyzed and in
          these cases, the ring is almost always accompanied by deletions of
          20pter and/or 20qter.
        explanation: >-
          Independent confirmation that the non-mosaic form carries terminal
          deletions.
  - name: Mitotic Ring Instability and Dynamic Mosaicism
    biological_scale: CELLULAR
    description: >-
      A circular chromosome is mechanically awkward at mitosis. Sister chromatid
      exchange within a ring produces interlocked or double-sized rings that
      segregate badly, so ring-bearing lineages continuously generate secondary
      aberrations and cells that have lost the ring entirely. This continuous
      reshuffling is called dynamic mosaicism, and it is the accepted explanation
      for the growth failure of the general ring syndrome. Whether it is also what
      drives the ring 20 epilepsy is proposed rather than established, which is
      why the arrow from here into the hub node is one of the open questions
      recorded in the discussions block.
    biological_processes:
      - preferred_term: chromosome segregation
        term:
          id: GO:0007059
          label: chromosome segregation
        modifier: ABNORMAL
    downstream:
      - target: Ring Ratio-Dependent Cortical Network Dysfunction
    evidence:
      - reference: PMID:28127864
        reference_title: >-
          Continuing role for classical cytogenetics: Case report of a boy with
          ring syndrome caused by complete ring chromosome 4 and review of
          literature.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Ring syndrome is thought to be caused by "dynamic mosaicism" due to ring
          instability.
        explanation: >-
          States the dynamic mosaicism hypothesis. Marked PARTIAL because it is
          offered for the general ring syndrome in a ring chromosome 4 case, not
          demonstrated for the ring 20 epilepsy phenotype.
      - reference: PMID:33207017
        reference_title: Transcriptome analysis of a ring chromosome 20 patient cohort.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          there may be genome-wide chromosomal instability affecting gene
          expression
        explanation: >-
          Raises genome-wide instability as a confounder and candidate mechanism
          in ring 20 specifically. Marked PARTIAL because the authors raise it as
          an interpretive caution rather than measuring it.
  - name: Ring Ratio-Dependent Cortical Network Dysfunction
    biological_scale: TISSUE
    description: >-
      The unresolved step. Something about carrying the ring makes cortex
      epileptogenic, in proportion to how many cells carry it, without any lesion
      visible on imaging and without a neurological deficit on examination before
      seizures start. Two concrete candidate mechanisms have been tested and
      disfavoured: deletion of candidate genes on chromosome 20, which cannot
      apply to the mosaic majority who delete nothing, and altered expression of
      genes near the fusion point, which a patient transcriptome study looked for
      and did not find. This node exists so that the graph does not paper over
      that gap; it is a placeholder for a real biological step whose content is
      unknown, not a claim.
    locations:
      - preferred_term: frontal lobe
        term:
          id: UBERON:0016525
          label: frontal lobe
    downstream:
      - target: Frontally Predominant Cortical Hyperexcitability
    evidence:
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          While the underlying etiology of the phenotype is still not understood,
          evidence is accumulating which suggests the deletion of candidate genes
          on chromosome 20 is not responsible.
        explanation: >-
          States both halves of what this node encodes: that the step is
          unexplained, and that the obvious gene-deletion explanation has been
          disfavoured.
      - reference: PMID:33207017
        reference_title: Transcriptome analysis of a ring chromosome 20 patient cohort.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          the mechanism by which individuals with complete ring chromosomes
          develop seizures and other phenotypic abnormalities is not understood
        explanation: >-
          Confirms independently and more recently that the step modeled by this
          node has no established molecular content.
      - reference: PMID:9217679
        reference_title: >-
          Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic
          syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Neurological examination results were normal, and neuroimaging studies
          often failed to disclose a brain lesion.
        explanation: >-
          Establishes that the dysfunction is not accompanied by a structural
          lesion, which is why it is modeled as a network-level abnormality rather
          than as a malformation.
  - name: Frontally Predominant Cortical Hyperexcitability
    biological_scale: CELLULAR
    conforms_to: "epilepsy_excitation_inhibition_imbalance#Neuronal Hyperexcitability and Hypersynchrony"
    description: >-
      Whatever the upstream cause, the network output is a hyperexcitable,
      hypersynchronous cortex with a frontal accent. The electroencephalographic
      signature is not the brief spike-wave of the generalized epilepsies but
      long-lasting bilateral high-voltage slow waves with only occasional spike
      components, often rhythmic theta with frontal predominance. The relative
      poverty of the spike component, alongside seizures that are clinically
      subtle relative to how dramatic the tracing looks, is a recurring
      observation and the seed of a genuine dispute about whether this pattern is
      ictal at all.
    cell_types:
      - preferred_term: pyramidal neuron
        term:
          id: CL:0000598
          label: pyramidal neuron
    biological_processes:
      - preferred_term: regulation of postsynaptic membrane potential
        term:
          id: GO:0060078
          label: regulation of postsynaptic membrane potential
        modifier: ABNORMAL
    downstream:
      - target: Nigrostriatal Seizure-Termination Failure
      - target: Drug-Resistant Focal Epilepsy
    evidence:
      - reference: PMID:9217679
        reference_title: >-
          Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic
          syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          an ictal EEG pattern of long-lasting bilateral paroxysmal high-voltage
          slow waves with occasional spikes
        explanation: >-
          Describes the characteristic electrographic pattern that defines this
          node.
      - reference: PMID:22424860
        reference_title: >-
          Ring chromosome 20 syndrome: electroclinical description of six patients
          and review of the literature.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Electroencephalogram recordings showed rhythmic theta waves with frontal
          predominance and non-convulsive status epilepticus (NCSE).
        explanation: >-
          Supports the frontal predominance asserted in this node's name.
  - name: Nigrostriatal Seizure-Termination Failure
    biological_scale: TISSUE
    description: >-
      The most distinctive thing about r(20) seizures is not that they start but
      that they will not stop, and this node is the reason to think that is a
      separate defect rather than just severe ictogenesis. Basal ganglia circuits,
      and striatal dopaminergic transmission in particular, are thought to
      interrupt seizures rather than generate them. In r(20), fluorodopa uptake is
      significantly reduced in both putamen and caudate, and functional imaging
      during an actual seizure shows the substantia nigra and striatum lighting up
      alongside frontal cortex. Notably the dopaminergic reduction does not track
      the ring ratio, so it behaves like a property of the syndrome rather than a
      dose effect. A seizure-stopping system that works poorly is exactly what a
      syndrome defined by days-long nonconvulsive status looks like from the
      inside.
    locations:
      - preferred_term: substantia nigra
        term:
          id: UBERON:0002038
          label: substantia nigra
      - preferred_term: striatum
        term:
          id: UBERON:0002435
          label: striatum
    downstream:
      - target: Prolonged Nonconvulsive Status Epilepticus
    evidence:
      - reference: PMID:15249613
        reference_title: >-
          PET evidence for a role of the basal ganglia in patients with ring
          chromosome 20 epilepsy.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Striatal dopamine is modulated in r(20) epilepsy; dysfunction of this
          neurotransmission may impair the mechanisms that interrupt seizures.
        explanation: >-
          States the seizure-termination hypothesis that this node encodes, from
          the study that measured it.
      - reference: PMID:15249613
        reference_title: >-
          PET evidence for a role of the basal ganglia in patients with ring
          chromosome 20 epilepsy.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          This reduction was equal for both nuclei and was not correlated to the
          percentage of cells with r(20).
        explanation: >-
          Shows the dopaminergic deficit is independent of ring ratio, which is why
          it is modeled as its own node rather than as another consequence of ring
          burden.
      - reference: PMID:22738216
        reference_title: >-
          Ictal involvement of the nigrostriatal system in subtle seizures of ring
          chromosome 20 epilepsy.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          We observed ictal BOLD increments in a cortical-subcortical network
          involving substantia nigrastriatum and frontal cortex.
        explanation: >-
          Functional imaging during an actual seizure showing the nigrostriatal
          system engaged, which is the direct observation behind this node. Single
          patient, so the node is supported rather than established.
  - name: Prolonged Nonconvulsive Status Epilepticus
    biological_scale: ORGANISM
    description: >-
      The most characteristic clinical event: a long confusional state, sometimes
      lasting days, during which awareness fluctuates and the patient may still
      respond to speech. It is easy to mistake for a behavioural change or a bad
      day, which is why the consensus advice is to have a low threshold for
      video-electroencephalography whenever behaviour or alertness shifts. It
      recurs, it is refractory to the drugs that do control the overt focal
      seizures, and it is the main driver of the encephalopathic decline.
    downstream:
      - target: Cognitive Decline and Behavioural Disturbance
    evidence:
      - reference: PMID:9217679
        reference_title: >-
          Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic
          syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          frequent seizures consisting of a prolonged confusional state, with or
          without additional motor seizures
        explanation: >-
          Defines the cardinal clinical event modeled by this node.
      - reference: PMID:16128150
        reference_title: >-
          Ring chromosome 20 with nonconvulsive status epilepticus:
          electroclinical correlation of a rare epileptic syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Twenty-four-hour video/EEG telemetry recorded during the NCSE showed
          fluctuating consciousness between overt unresponsiveness and normal
          awareness.
        explanation: >-
          Documents the fluctuating awareness that makes the episodes hard to
          recognize clinically.
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          often evolving into epileptic encephalopathy associated with
          non-convulsive status epilepticus (11 patients)
        explanation: >-
          Links the status epilepticus to the encephalopathic outcome that this
          node feeds.
  - name: Drug-Resistant Focal Epilepsy
    biological_scale: ORGANISM
    conforms_to: "epilepsy_excitation_inhibition_imbalance#Recurrent Unprovoked Seizures"
    description: >-
      Alongside the status episodes, patients have recurrent focal seizures:
      dyscognitive seizures, focal motor seizures often arising from sleep, and
      characteristically terrifying hallucinations at onset in childhood. Later in
      the course focal seizures with motor and autonomic features and eyelid
      myoclonia appear. Drug resistance is close to the rule, and the current
      consensus is that families should be told at diagnosis that the seizures are
      likely to be lifelong.
    downstream:
      - target: Cognitive Decline and Behavioural Disturbance
    evidence:
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          When seizure onset occurred in childhood (21 patients), terrifying
          hallucinations associated with focal motor seizures, often sleep-related
          (8 patients), or dyscognitive seizures (13 patients), were prominent
          features
        explanation: >-
          Enumerates the focal seizure semiology this node asserts, in the largest
          single series.
      - reference: PMID:22424860
        reference_title: >-
          Ring chromosome 20 syndrome: electroclinical description of six patients
          and review of the literature.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          All patients presented with pharmacoresistant frontal lobe complex
          partial seizures.
        explanation: >-
          Supports both the focal frontal character and the drug resistance.
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          if patients are diagnosed with epilepsy, they and their families should
          be counseled that seizures are likely to be drug-resistant and life-long
        explanation: >-
          States the expert consensus on prognosis, which is the practical content
          of drug resistance here.
  - name: Cognitive Decline and Behavioural Disturbance
    biological_scale: ORGANISM
    description: >-
      Children who were developing normally lose ground after seizures begin,
      accumulating intellectual disability and behavioural problems, and the
      severity tracks both the ring ratio and how early the seizures started. That
      pattern is what earns the syndrome its classification as a developmental and
      epileptic encephalopathy. The classification is not unchallenged: behavioural
      disturbance has been reported to begin before the first seizure in some
      patients, which would make part of the cognitive phenotype a parallel effect
      of the ring rather than a consequence of the epilepsy. That dispute is
      recorded in the discussions block.
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          r(20) syndrome is characterized by a recognizable epileptic phenotype
          with typical EEG pattern, intellectual disability manifesting after
          seizure onset in otherwise normally developing children, and behavioral
          changes.
        explanation: >-
          States the post-seizure-onset timing of the cognitive decline that
          underpins the encephalopathy framing.
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The r(20) ratio and severity of cognitive impairment appear to be
          directly related to each other and inversely correlated with the age at
          epilepsy onset.
        explanation: >-
          Quantifies the relationship between ring burden, seizure onset age, and
          cognitive outcome that this node depends on.
phenotypes:
  - category: Neurologic
    name: Drug-resistant focal epilepsy
    description: >-
      Childhood-onset focal seizures that persist through adult life and respond
      poorly to antiseizure medication. Frontal lobe semiology predominates.
    phenotype_term:
      preferred_term: Focal impaired awareness seizure
      term:
        id: HP:0002384
        label: Focal impaired awareness seizure
      clinical_course: PROGRESSIVE
    frequency: FREQUENT
    evidence:
      - reference: PMID:42468067
        reference_title: >-
          Delineating the epilepsy phenotype of ring chromosome 20: A systematic
          literature review.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Focal seizures with impaired consciousness were most common (n = 94/187,
          50.3%).
        explanation: >-
          94 of 187 pooled patients, which is 50.3 percent and falls in the
          FREQUENT band, and establishes this as the commonest single seizure type.
      - reference: PMID:42468067
        reference_title: >-
          Delineating the epilepsy phenotype of ring chromosome 20: A systematic
          literature review.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The median number of ASMs tried was 4 (2,7); most patients (80%, n =
          92/115) were drug-resistant.
        explanation: >-
          Quantifies the drug resistance asserted in this phenotype's name across
          the pooled literature.
      - reference: PMID:22424860
        reference_title: >-
          Ring chromosome 20 syndrome: electroclinical description of six patients
          and review of the literature.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          All patients presented with pharmacoresistant frontal lobe complex
          partial seizures.
        explanation: >-
          Documents focal impaired-awareness seizures with drug resistance in
          every patient of the series.
      - reference: PMID:9217679
        reference_title: >-
          Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic
          syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The seizures were resistant to antiepileptic drug therapy.
        explanation: >-
          Independent confirmation of drug resistance in the founding case series.
  - category: Neurologic
    name: Nonconvulsive status epilepticus
    description: >-
      Recurrent prolonged confusional states with fluctuating awareness and a
      long-lasting rhythmic slow-wave electroencephalographic pattern. The single
      most characteristic feature of the syndrome.
    phenotype_term:
      preferred_term: Non-convulsive status epilepticus without coma
      term:
        id: HP:0032671
        label: Non-convulsive status epilepticus without coma
      temporality: RECURRENT
    frequency: VERY_FREQUENT
    evidence:
      - reference: PMID:42468067
        reference_title: >-
          Delineating the epilepsy phenotype of ring chromosome 20: A systematic
          literature review.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Information on non-convulsive status epilepticus (NCSE) was available in
          143 cases; 126 had experienced NCSE (88%).
        explanation: >-
          126 of 143 patients across 71 studies, which is 88 percent and falls in
          the VERY_FREQUENT band. The denominator is all r(20) patients with the
          information available rather than a status-selected subgroup, so the
          estimate is not circular. This systematic review supersedes the smaller
          single-series estimate for the purpose of the band.
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          often evolving into epileptic encephalopathy associated with
          non-convulsive status epilepticus (11 patients)
        explanation: >-
          Eleven of 25 in a single series, which is lower than the pooled figure.
          Marked PARTIAL because a single centre series is a weaker basis for the
          band than the systematic review, and it is retained to show the spread
          between reports rather than to set the band.
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          as there is a high incidence of non-convulsive status epilepticus
          (NCSE), there should be a low threshold for video-EEG monitoring if
          patients have a change in behavior or level of consciousness
        explanation: >-
          Corroborates the high frequency and states its clinical consequence for
          monitoring.
  - category: Neurologic
    name: EEG abnormality with long-lasting rhythmic slow waves
    description: >-
      A distinctive tracing: prolonged bilateral high-voltage slow waves with only
      occasional spike components, often rhythmic theta with frontal predominance,
      lasting far longer than an ordinary electrographic seizure.
    phenotype_term:
      preferred_term: EEG abnormality
      term:
        id: HP:0002353
        label: EEG abnormality
    evidence:
      - reference: PMID:9217679
        reference_title: >-
          Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic
          syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          an ictal EEG pattern of long-lasting bilateral paroxysmal high-voltage
          slow waves with occasional spikes
        explanation: >-
          Describes the characteristic pattern.
      - reference: PMID:16128150
        reference_title: >-
          Ring chromosome 20 with nonconvulsive status epilepticus:
          electroclinical correlation of a rare epileptic syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The EEG consisted of long-lasting generalized rhythmic 3-5 Hz sharp or
          slow waves with a few spikes, lasting several days.
        explanation: >-
          Quantifies the frequency band and the extraordinary duration.
  - category: Neurologic
    name: Intellectual disability
    description: >-
      Mild to severe cognitive impairment that typically emerges after seizure
      onset in children who were developing normally, with severity tracking the
      ring ratio and inversely tracking age at seizure onset.
    phenotype_term:
      preferred_term: Intellectual disability
      term:
        id: HP:0001249
        label: Intellectual disability
      clinical_course: PROGRESSIVE
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          intellectual disability manifesting after seizure onset in otherwise
          normally developing children
        explanation: >-
          States the characteristic timing of the cognitive impairment.
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          We found statistically significant correlations between age at epilepsy
          onset and cognitive level.
        explanation: >-
          Supports the relationship between seizure onset age and cognitive
          outcome.
  - category: Behavioral
    name: Behavioural disturbance
    description: >-
      Behavioural problems are a consistent part of the syndrome and, importantly,
      have been reported to begin before the first seizure in a substantial
      fraction of patients, which is one of the arguments against reading the whole
      cognitive-behavioural phenotype as a consequence of the epilepsy.
    phenotype_term:
      preferred_term: Atypical behavior
      term:
        id: HP:0000708
        label: Atypical behavior
    evidence:
      - reference: PMID:22424860
        reference_title: >-
          Ring chromosome 20 syndrome: electroclinical description of six patients
          and review of the literature.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          There were three patients out of six with behavioral disturbances before
          the onset of seizures.
        explanation: >-
          Documents behavioural disturbance preceding seizure onset, the
          observation that motivates the encephalopathy controversy in the
          discussions block.
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Ring Chromosome 20 syndrome is a rare chromosomal disorder characterized
          by refractory epilepsy, with seizures in wakefulness and sleep,
          behavioral problems and mild to severe cognitive impairment.
        explanation: >-
          Establishes behavioural problems as a defining component of the
          syndrome.
  - category: Neurologic
    name: Ictal fear
    description: >-
      Fear as the seizure itself rather than as a reaction to it. It is the single
      most characteristic subjective feature of r(20) seizures, reported in nearly
      three quarters of patients for whom the information exists, and it is a
      frequent reason these children are sent to psychiatry before anyone orders a
      karyotype.
    phenotype_term:
      preferred_term: ictal fear
      term:
        id: HP:0032739
        label: Focal emotional seizure with fear/anxiety/panic
    frequency: FREQUENT
    evidence:
      - reference: PMID:42468067
        reference_title: >-
          Delineating the epilepsy phenotype of ring chromosome 20: A systematic
          literature review.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Seventy-eight patient reports reported the presence of ictal fear, which
          was present in 56 cases (72%).
        explanation: >-
          56 of 78 patients for whom the feature was reported, which is 72 percent
          and falls in the FREQUENT band. The denominator is restricted to reports
          that addressed ictal fear at all, which is stated here because that is a
          narrower base than the full 192-patient cohort.
      - reference: PMID:42468067
        reference_title: >-
          Delineating the epilepsy phenotype of ring chromosome 20: A systematic
          literature review.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Ring chromosome 20 is characterized by childhood-onset drug-resistant
          epilepsy, predominantly focal with ictal fear and NCSE.
        explanation: >-
          States ictal fear as one of the three defining features of the epilepsy
          phenotype.
  - category: Neurologic
    name: Hallucinations at seizure onset
    description: >-
      Terrifying hallucinations at the start of a seizure are a distinctive and
      clinically memorable feature of childhood-onset cases, and are among the
      reasons the syndrome is sometimes first referred to psychiatry.
    phenotype_term:
      preferred_term: Hallucinations
      term:
        id: HP:0000738
        label: Hallucinations
    evidence:
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          terrifying hallucinations associated with focal motor seizures, often
          sleep-related (8 patients), or dyscognitive seizures (13 patients), were
          prominent features
        explanation: >-
          Documents ictal hallucinations as a prominent feature of childhood-onset
          cases.
  - category: Neurologic
    name: Focal motor seizure
    description: >-
      Focal motor seizures, frequently arising out of sleep, occurring alongside
      the dyscognitive events. Later in the course focal seizures acquire motor and
      autonomic features.
    phenotype_term:
      preferred_term: Focal motor seizure
      term:
        id: HP:0011153
        label: Focal motor seizure
    evidence:
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          In the long-term, progressive stabilization of drug resistant epilepsy
          associated with non-convulsive status epilepticus, focal seizures with
          motor and autonomic features, and eyelid myoclonia were noticed.
        explanation: >-
          Documents focal motor seizures in the long-term course of the syndrome.
  - category: Neurologic
    name: Eyelid myoclonia seizure
    description: >-
      Rapid jerking of the eyelids as a seizure type appearing in the long-term
      course, a feature the syndrome shares with several generalized epilepsies and
      one that can misdirect the diagnosis.
    phenotype_term:
      preferred_term: Eyelid myoclonia seizure
      term:
        id: HP:0032678
        label: Eyelid myoclonia seizure
    evidence:
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          In the long-term, progressive stabilization of drug resistant epilepsy
          associated with non-convulsive status epilepticus, focal seizures with
          motor and autonomic features, and eyelid myoclonia were noticed.
        explanation: >-
          Documents eyelid myoclonia in the long-term seizure repertoire.
prevalence:
  - population: Published cases worldwide
    measure_type: CASES_IN_LITERATURE
    prevalence_class: ULTRA_RARE
    notes: >-
      No population-based prevalence estimate exists. About 200 children and adults
      had been reported in the literature as of 2020, roughly five decades after
      the first case; the 2012 count of more than 100 is retained alongside it to
      show the trajectory. The count is almost certainly an undercount, because the
      mosaic majority is invisible to
      chromosomal microarray and the syndrome carries no dysmorphic signature to
      prompt a karyotype.
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          about 200 pediatric and adult individuals with r(20) syndrome have been
          reported in the literature
        explanation: >-
          The current published case count, from the 2020 review, superseding the
          2012 figure below.
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          More than 100 cases have been published since the initial report in
          1972.
        explanation: >-
          Gives the published case count that this record reports.
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Cytogenetic analysis, rather than chromosomal microarray analysis is
          recommended for diagnosis of this syndrome, as the mosaic cases do not
          have copy number alterations and are therefore not identified by
          array-based analysis.
        explanation: >-
          Supports the ascertainment argument in the notes, that the diagnostic
          pathway systematically misses mosaic cases.
progression:
  - phase: Seizure onset in a normally developing child
    age_range: Early childhood to adolescence
    notes: >-
      Onset is typically around school age in mosaic patients and several years
      earlier in the non-mosaic group, with a higher ring ratio predicting earlier
      onset. Development is normal beforehand, and there is usually neither
      dysmorphism nor a brain lesion, which is why the diagnosis is often delayed
      for years.
    evidence:
      - reference: PMID:20972251
        reference_title: >-
          Molecular analysis of ring chromosome 20 syndrome reveals two distinct
          groups of patients.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The age of onset of seizures was significantly lower in the non-mosaic
          patients (group 2, median age of onset 2.1 years) than in the mosaic
          patients (group 1, median age of onset 6.0 years).
        explanation: >-
          Provides the onset ages for both structural groups.
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Facial dysmorphism or other congenital malformations are rarely reported
          making it difficult to diagnose the syndrome based on clinical findings
          alone.
        explanation: >-
          Supports the diagnostic delay described in this phase.
  - phase: Evolution to epileptic encephalopathy with recurrent status
    age_range: Childhood into adult life
    notes: >-
      Childhood-onset cases commonly evolve into an epileptic encephalopathy with
      recurrent nonconvulsive status epilepticus and cognitive decline. Onset in
      adolescence carries a milder course with dyscognitive seizures and status
      episodes but without cognitive decline, so age at onset is the main
      prognostic variable.
    evidence:
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Epilepsy onset in adolescence (3 patients) was accompanied by a milder
          developmental course, dyscognitive seizures and non-convulsive status
          epilepticus, and no cognitive decline.
        explanation: >-
          Documents the milder adolescent-onset trajectory that contrasts with the
          childhood-onset encephalopathy.
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          In ring(20) syndrome, epilepsy has an age dependent course and a worse
          outcome when age at seizure onset is earlier.
        explanation: >-
          States the age-dependence of outcome that defines this phase.
  - phase: Long-term persistence with rare remission
    age_range: Adulthood
    notes: >-
      Epilepsy continues through adult life and stabilizes rather than remits.
      Seizure freedom of more than five years was reached by only three of 25
      patients in the largest series, all of them older, so remission is possible
      but should not be expected.
    evidence:
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Only three older patients became seizure free (>5 years)
        explanation: >-
          Quantifies how rarely long-term seizure freedom is achieved.
      - reference: PMID:22424860
        reference_title: >-
          Ring chromosome 20 syndrome: electroclinical description of six patients
          and review of the literature.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The ring chromosome 20 syndrome is characterized by childhood-onset
          refractory epilepsy continuing throughout adult life, mental disability,
          and behavioral disturbances which can originate before seizure onset.
        explanation: >-
          Supports persistence of the epilepsy into adult life.
treatments:
  - name: Oral antiseizure medication
    description: >-
      First-line treatment is an oral antiseizure medication, but expectations
      should be set low. Notably, drugs can substantially reduce the overt focal
      seizures while leaving the electrographic status pattern untouched, a
      dissociation that is clinically important and is also one of the arguments in
      the dispute over whether that pattern is really ictal.
    therapeutic_modality: SMALL_MOLECULE
    treatment_term:
      preferred_term: Pharmacotherapy
      term:
        id: NCIT:C15986
        label: Pharmacotherapy
      therapeutic_agent:
        - preferred_term: valproic acid
          term:
            id: CHEBI:39867
            label: valproic acid
        - preferred_term: lamotrigine
          term:
            id: CHEBI:6367
            label: lamotrigine
    target_mechanisms:
      - target: Frontally Predominant Cortical Hyperexcitability
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          initial epilepsy treatment should be with an oral anti-seizure
          medication
        explanation: >-
          States the consensus first-line recommendation, which is deliberately
          agent-agnostic.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          In our experience, valproic acid and lamotrigine, often in combination,
          are generally the most effective antiepileptic drugs (AEDs) for treating
          seizures in r(20)
        explanation: >-
          Names the two agents recorded in therapeutic_agent. Marked PARTIAL
          because it is explicitly expert experience rather than trial evidence,
          which is the standard of evidence available for drug choice in this
          syndrome.
      - reference: PMID:16128150
        reference_title: >-
          Ring chromosome 20 with nonconvulsive status epilepticus:
          electroclinical correlation of a rare epileptic syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Oral AEDs decreased more than 75% of the overt CPS episodes in both
          patients at 22 and 26 months of follow-up but had no effect on the
          natural history of electrical NCSE.
        explanation: >-
          Documents the partial and selective response that this treatment record
          describes. Marked PARTIAL because it is a two-patient observation and
          shows benefit for one seizure type only.
  - name: Home rescue medication for prolonged seizures
    description: >-
      Because prolonged seizures and nonconvulsive status are expected rather than
      exceptional, the consensus is to supply a rescue medication for use at home
      rather than relying on emergency presentation each time.
    therapeutic_modality: SMALL_MOLECULE
    treatment_term:
      preferred_term: Pharmacotherapy
      term:
        id: NCIT:C15986
        label: Pharmacotherapy
    target_mechanisms:
      - target: Prolonged Nonconvulsive Status Epilepticus
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          home rescue medication should be considered given the risk for prolonged
          seizures and NCSE
        explanation: >-
          States the consensus recommendation and its rationale.
  - name: Ketogenic diet
    description: >-
      A non-pharmacological option offered when medications fail. It is
      recommended on the strength of expert consensus and small reports rather
      than controlled data, a limitation the consensus statement is explicit
      about.
    therapeutic_modality: BEHAVIORAL
    treatment_term:
      preferred_term: Ketogenic Diet
      term:
        id: NCIT:C173168
        label: Ketogenic Diet
    target_mechanisms:
      - target: Frontally Predominant Cortical Hyperexcitability
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          for patients with drug-resistant epilepsy, ketogenic diet, vagus nerve
          stimulation, or deep brain stimulation could all be considered
        explanation: >-
          Names the ketogenic diet as a consensus option for drug-resistant cases.
          Marked PARTIAL because the same review states the evidence base is
          weak.
  - name: Vagus nerve stimulation
    description: >-
      Implanted neurostimulation offered for drug-resistant seizures. As with the
      other second-line options, the recommendation rests on consensus and case
      experience, and it should be offered with the caveat that its efficacy in
      this syndrome specifically is described in the literature as controversial
      rather than established.
    therapeutic_modality: DEVICE
    treatment_term:
      preferred_term: vagus nerve stimulation
      term:
        id: NCIT:C49236
        label: Therapeutic Procedure
    target_mechanisms:
      - target: Frontally Predominant Cortical Hyperexcitability
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          for patients with drug-resistant epilepsy, ketogenic diet, vagus nerve
          stimulation, or deep brain stimulation could all be considered
        explanation: >-
          Names vagus nerve stimulation as a consensus option. Marked PARTIAL
          because no controlled evidence in this syndrome is cited. NCIT has no
          specific vagus nerve stimulation clinical-action term, so the generic
          Therapeutic Procedure term is used with a specific preferred_term.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          the efficacy of vagal nerve stimulation is controversial
        explanation: >-
          Qualifies the consensus recommendation. Marked PARTIAL because it
          reports disagreement in the literature rather than a negative result, but
          it is the reason this record does not read as an established option.
  - name: Deep brain stimulation
    description: >-
      Deep brain stimulation is listed alongside vagus nerve stimulation as an
      option for drug-resistant seizures, and is of particular interest here
      because the epilepsy has no resectable focus, ruling out the surgical route
      that helps other drug-resistant focal epilepsies.
    therapeutic_modality: DEVICE
    treatment_term:
      preferred_term: Deep Brain Stimulation
      term:
        id: NCIT:C21024
        label: Deep Brain Stimulation
    target_mechanisms:
      - target: Frontally Predominant Cortical Hyperexcitability
        treatment_effect: INHIBITS
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          for patients with drug-resistant epilepsy, ketogenic diet, vagus nerve
          stimulation, or deep brain stimulation could all be considered
        explanation: >-
          Names deep brain stimulation as a consensus option. Marked PARTIAL for
          the same reason as the other second-line recommendations.
  - name: Multidisciplinary allied health support
    description: >-
      Because the disability is cognitive and behavioural as much as it is
      seizure-related, the consensus is that care should be delivered by a team
      including speech, occupational, physical, and psychological therapy rather
      than by an epileptologist alone. Caregiver burnout is explicitly named as
      something to screen for.
    therapeutic_modality: BEHAVIORAL
    treatment_term:
      preferred_term: Supportive Care
      term:
        id: NCIT:C15747
        label: Supportive Care
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          The care team should be multidisciplinary and include at least an
          epileptologist and allied health specialists (e.g., speech therapist,
          occupational therapist, physiotherapist, psychologist)
        explanation: >-
          States the consensus recommendation on care organization.
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          caregiver burnout and stress should be screened for and supports
          provided
        explanation: >-
          Supports the caregiver component of the recommendation.
  - name: Genetic counselling
    description: >-
      Referral for genetic counselling is recommended for all patients and
      families. The counselling content is unusual for a chromosomal disorder,
      since the ring is nearly always de novo and postzygotic and the ring fraction
      rather than any deleted gene is what predicts severity.
    therapeutic_modality: BEHAVIORAL
    treatment_term:
      preferred_term: Genetic Counseling
      term:
        id: NCIT:C15240
        label: Genetic Counseling
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          patients and families should be referred for genetic counseling
        explanation: >-
          States the consensus recommendation.
diagnosis:
  - name: Karyotype with adequate cell counts
    description: >-
      The diagnostic test, and a rare instance in modern practice where the older
      technology is the correct one. Because most patients are mosaic and carry no
      copy number change, a chromosomal microarray returns normal. Enough
      metaphase cells must be scored to detect a low ring fraction and to estimate
      the ring ratio, which is itself prognostically informative.
    diagnosis_term:
      preferred_term: Karyotyping
      term:
        id: NCIT:C16768
        label: Karyotyping
    results: >-
      A ring chromosome 20 replacing one normal chromosome 20, typically in a
      fraction of cells, reported with the proportion of ring-bearing metaphases.
    evidence:
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Cytogenetic analysis, rather than chromosomal microarray analysis is
          recommended for diagnosis of this syndrome, as the mosaic cases do not
          have copy number alterations and are therefore not identified by
          array-based analysis.
        explanation: >-
          States the diagnostic recommendation and the reason microarray fails.
      - reference: PMID:25957205
        reference_title: Ring (20) chromosome epileptic syndrome.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          we emphasize the importance of early G-banding chromosomal analysis when
          patients present with unexplainable severe seizures and repetitive NCSE,
          even in the absence of any dysmorphic features suggestive of a
          chromosomal disorder
        explanation: >-
          States the clinical trigger for ordering the karyotype, which is the
          practical diagnostic message of this record.
  - name: Video-electroencephalography during behavioural change
    description: >-
      Prolonged video-electroencephalography is how nonconvulsive status is caught,
      and the threshold for ordering it should be low, because the clinical
      presentation is a change in behaviour or alertness rather than anything that
      looks like a seizure.
    diagnosis_term:
      preferred_term: Electroencephalography
      term:
        id: NCIT:C38054
        label: Electroencephalography
    results: >-
      Long-lasting bilateral high-voltage rhythmic slow waves at roughly 3 to 5
      hertz with sparse spike components, sometimes persisting for days, with
      fluctuating clinical responsiveness.
    evidence:
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          as there is a high incidence of non-convulsive status epilepticus
          (NCSE), there should be a low threshold for video-EEG monitoring if
          patients have a change in behavior or level of consciousness
        explanation: >-
          States the consensus indication for the test.
      - reference: PMID:16128150
        reference_title: >-
          Ring chromosome 20 with nonconvulsive status epilepticus:
          electroclinical correlation of a rare epileptic syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The EEG consisted of long-lasting generalized rhythmic 3-5 Hz sharp or
          slow waves with a few spikes, lasting several days.
        explanation: >-
          Provides the electrographic findings reported in the results field.
differential_diagnoses:
  - name: Lennox-Gastaut Syndrome
    disease_term:
      preferred_term: Lennox-Gastaut syndrome
      term:
        id: MONDO:0016532
        label: Lennox-Gastaut syndrome
    description: >-
      The commonest misdiagnosis, because both present as drug-resistant
      childhood-onset epilepsy with cognitive decline and frequent nonconvulsive
      status. The route out is the karyotype, not the clinical picture.
    distinguishing_features:
      - Slow spike-wave at 1.5 to 2.5 hertz and generalized paroxysmal fast activity, rather than long-lasting rhythmic slow waves with sparse spikes.
      - Tonic seizures in sleep are a defining feature and are not characteristic of ring 20.
      - Frequently follows an identifiable structural or genetic cause; ring 20 has neither a lesion nor a causal gene.
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          The Authors report that the differential diagnosis might be challenging
          especially with: (1) Frontal Lobe Seizures; (2) Rolandic Epilepsy treated
          with sodium channel blockers (NCSE during wakefulness); and (3)
          Lennox-Gastaut syndrome (LGS).
        explanation: >-
          Names Lennox-Gastaut syndrome explicitly as one of the three hardest
          differentials for this syndrome, rather than merely establishing that
          differentials exist.
  - name: Familial Sleep Related Hypermotor Epilepsy
    disease_term:
      preferred_term: familial sleep-related hypermotor epilepsy
      term:
        id: MONDO:0000030
        label: familial sleep-related hypermotor epilepsy
    description: >-
      Shares frontal lobe seizures arising from sleep, and is additionally
      confusable because its first identified gene, CHRNA4, sits on distal
      chromosome 20q and was for that reason a natural candidate for ring 20.
      The candidate did not survive scrutiny, since the mosaic majority delete
      nothing.
    distinguishing_features:
      - Autosomal dominant family history rather than a de novo chromosomal event.
      - Normal cognition and normal interictal electroencephalogram between events.
      - No nonconvulsive status epilepticus and no long-lasting rhythmic slow-wave pattern.
      - Karyotype is normal.
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          These features are often present in frontal lobe seizures of different
          etiologies (83), but the absence of NCSE and of the typical EEG features
          of r(20) syndrome are helpful in the diagnosis.
        explanation: >-
          Names the two features that separate ring 20 from other frontal lobe
          epilepsies, which is precisely the discriminating information this
          differential needs.
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Ring Chromosome 20 syndrome is a rare chromosomal disorder characterized
          by refractory epilepsy, with seizures in wakefulness and sleep,
          behavioral problems and mild to severe cognitive impairment.
        explanation: >-
          Documents that ring 20 seizures occur in both wakefulness and sleep and
          are accompanied by cognitive impairment, which is what separates it from
          a pure sleep-related frontal epilepsy with preserved cognition.
  - name: Ring Chromosome 14 Syndrome
    disease_term:
      preferred_term: ring chromosome 14
      term:
        id: MONDO:0014708
        label: ring chromosome 14
    description: >-
      The nearest structural analogue: another ring chromosome syndrome with
      drug-resistant epilepsy, intellectual disability, behavioural change,
      frequent status, and the same correlation between ring ratio and severity.
      It is the natural control for any theory of why rings cause epilepsy, since
      whatever explains r(20) has to explain why r(14) differs and why r(2) and
      r(4) produce no epilepsy at all.
    distinguishing_features:
      - Seizures usually begin in the first months or years of life rather than at school age.
      - A distinctive facial appearance is present, whereas ring 20 characteristically has none.
      - Ocular manifestations occur that have never been reported in ring 20.
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Status epilepticus is frequent, but seizures usually start in the first
          months/years of life, unlike in r(20) syndrome. Moreover, individuals
          with r(14) usually present with a distinctive facial appearance
          (epicanthic folds, down-slanting palpebral fissures, flat nasal bridge,
          upturned nares, and large low-set ears) and exhibit ocular manifestations
          that have never been reported in r(20) syndrome, thus facilitating
          distinguishing these two conditions
        explanation: >-
          Supports all three distinguishing features directly: the earlier onset,
          the facial appearance, and the ocular findings absent from ring 20.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          However, even if patients with different ring chromosomes such as r(14)
          or r(17) manifest epilepsy, their seizures differ from those of r(20)
          patients
        explanation: >-
          Establishes that the epilepsies of the two ring syndromes are
          distinguishable, which is also a constraint on any generic ring
          mechanism.
  - name: Phelan-McDermid Syndrome
    disease_term:
      preferred_term: Phelan-McDermid syndrome
      term:
        id: MONDO:0011652
        label: Phelan-McDermid syndrome
    description: >-
      Another chromosomal disorder that pairs mild dysmorphism with intellectual
      disability, psychiatric symptoms, and seizures activated in sleep, so the
      clinical gestalt overlaps. The discriminator is the course of the epilepsy
      rather than its appearance at any one moment.
    distinguishing_features:
      - Epilepsy follows a benign course, whereas ring 20 seizures are usually drug-resistant.
      - Caused by 22q13.3 deletion, which chromosomal microarray detects and which ring 20 mosaicism does not resemble.
      - Interictal abnormalities are multifocal over frontal-central and frontal-temporal regions rather than the long rhythmic slow-wave pattern of ring 20.
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Although the typical EEG abnormalities seen in patients with
          Phelan-McDermid syndrome consist of multifocal paroxysmal anomalies that
          are prevalent over the frontal-central and frontal-temporal regions and
          are activated during sleep, epilepsy shows a benign course in these
          patients, unlike r(20) where seizures are usually drug-resistant
        explanation: >-
          Supports both the electrographic distinction and the decisive one, which
          is that the epilepsy is benign here and drug-resistant in ring 20.
  - name: Epilepsy with Myoclonic Atonic Seizures
    disease_term:
      preferred_term: epilepsy with myoclonic atonic seizures
      term:
        id: MONDO:0014633
        label: epilepsy with myoclonic atonic seizures
    description: >-
      Another childhood epileptic encephalopathy that enters the differential when
      a previously normal child develops drug-resistant seizures with cognitive
      regression and episodes of nonconvulsive status.
    distinguishing_features:
      - Myoclonic-atonic drop attacks are the defining seizure type and are not typical of ring 20.
      - Generalized rather than frontal focal semiology.
      - Often remits, whereas ring 20 epilepsy persists into adult life.
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Despite the distinctive phenotype, many patients still lack a
          diagnosis-especially in the genomic era-and the pathomechanisms of ring
          formation are poorly understood.
        explanation: >-
          Supports the claim that ring 20 is routinely missed and therefore
          confused with other childhood epileptic encephalopathies. Marked PARTIAL
          because it does not name this specific alternative diagnosis.
discussions:
  - discussion_id: r20_unexplained_female_excess
    kind: KNOWLEDGE_GAP
    status: OPEN
    prompt: >-
      Why are patients with mosaic ring chromosome 20 disproportionately female,
      when the ring arises postzygotically and involves an autosome?
    attaches_to:
      - pathophysiology#Postzygotic Mosaic Ring Without Detectable Deletion
      - pathophysiology#Telomere-Telomere Fusion Forming Ring Chromosome 20
    rationale: >-
      Chromosome 20 is an autosome and the mosaic ring forms after fertilization,
      so there is no obvious route by which sex should matter. Yet the sex ratio
      is consistently skewed: a systematic review of 192 patients found only 40
      percent male, and the skew has been reported specifically in the mosaic group
      rather than the non-mosaic one. Several explanations are available and none
      has been tested. It could be ascertainment, if girls with unexplained
      cognitive and behavioural decline are investigated differently from boys. It
      could be survival, if male embryos tolerate the ring and its ongoing
      instability less well, which would predict an excess of male losses rather
      than a female excess among survivors. It could reflect a genuine
      sex-dependent difference in tolerance of aneuploid or ring-bearing lineages
      during early development, which is testable. Or it could be a real but
      modest effect inflated by publication bias across a literature made almost
      entirely of case reports and small series. Which of these is right matters
      for whether the ratio is telling us something about ring biology or only
      about how the syndrome gets found.
    proposed_experiments:
      - experiment_id: exp_r20_unbiased_ascertainment_sex_ratio
        name: Sex ratio in a diagnostically unbiased ascertainment stream
        description: >-
          Determine the sex ratio among ring 20 cases found by routine karyotyping
          of all children meeting a pre-specified clinical trigger, such as
          drug-resistant focal epilepsy with recurrent confusional episodes,
          rather than among published cases. Prospective registry ascertainment
          with a fixed testing rule removes the referral asymmetry that the case
          literature cannot exclude.
        decision_criterion: >-
          A sex ratio near parity under a fixed testing rule would identify the
          published excess as ascertainment bias. A persistent female excess would
          make it a biological finding needing a mechanism.
    evidence:
      - reference: PMID:42468067
        reference_title: >-
          Delineating the epilepsy phenotype of ring chromosome 20: A systematic
          literature review.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Seventy-one studies were included (192 patients), 40.4% (n = 67/166)
          were male.
        explanation: >-
          Quantifies the sex skew across the pooled published literature, which is
          the observation this gap is about. It also shows the base is published
          cases, which is precisely why ascertainment cannot be excluded.
  - discussion_id: r20_mechanism_without_deletion
    kind: CONTROVERSY
    status: UNDER_DISCUSSION
    prompt: >-
      If most ring 20 patients lose no genetic material, what does the ring
      actually do to make cortex epileptogenic, and why has every concrete
      candidate mechanism tested so far failed?
    attaches_to:
      - pathophysiology#Ring Ratio-Dependent Cortical Network Dysfunction
      - pathophysiology#Mitotic Ring Instability and Dynamic Mosaicism
      - pathophysiology#Postzygotic Mosaic Ring Without Detectable Deletion
    rationale: >-
      This is the central unsolved problem of the syndrome and the reason the
      mechanism graph carries an explicitly empty hub node. Two candidate accounts
      have been put to the test and both came back negative. The first was gene
      dosage: distal chromosome 20q carries plausible epilepsy genes, notably the
      nicotinic receptor subunit CHRNA4 implicated in sleep-related frontal
      epilepsy, so deletion at the fusion point looked promising. It cannot be the
      general answer, because the mosaic majority have no detectable deletion in
      either cell line, and a review of the accumulated evidence concluded that
      candidate gene deletion is not responsible. The second was a position effect:
      circularizing a chromosome moves formerly telomeric regions into a new
      context and might silence or derepress genes near the join. A transcriptome
      study of a patient cohort looked specifically for that and found no altered
      expression in peritelomeric or other chromosome 20 regions, concluding that
      peritelomeric altered transcription is not the likely pathogenic mechanism.
      A third candidate has since been tested and also failed. If circularizing the
      chromosome silences subtelomeric genes through telomeric heterochromatin
      spreading, that silencing should show up as altered methylation; a
      genome-wide methylation screen in r(20) patients found no shared epigenetic
      signature anywhere, and specifically none at CHRNA4 or KCNQ2. The authors
      note the array covers subtelomeric regions poorly, so this is a strong
      negative rather than a conclusive one. There is also a cleaner argument
      against dosage than the absence of deletions: people who carry terminal
      deletions of chromosome 20 on an ordinary linear chromosome do not develop
      this epilepsy. Losing the material is not sufficient; the ring is doing
      something the deletion does not. What remains are less tractable hypotheses.
      Dynamic mosaicism, in which ring instability continuously generates secondary
      aberrations and ring-loss cells, is the accepted explanation for the growth
      failure of ring syndromes generally but has not been shown to drive the ring
      20 epilepsy, and it has a problem of its own: only 12 of 35 evaluated
      patients had secondary aberrations above a five percent threshold, so r(20)
      may simply not be unstable enough for the mechanism to bear the weight. A
      further constraint on any generic ring-based account is that ring chromosome
      2 and ring chromosome 4 patients do not develop epilepsy at all, so whatever
      the ring does, it does it in a chromosome-specific way. Genome-wide
      chromosomal instability affecting expression of genes not on chromosome 20 is
      raised by the same transcriptome study, which found candidate differences
      across many genes rather than a localized signal. Nuclear architecture is a
      third possibility that has barely been tested, since a ring occupies a
      different territory and has different lamina contacts than a rod. There is
      also a real methodological obstacle underlying all of this: the accessible
      tissue is blood, the diseased tissue is brain, and mosaicism means the two may
      differ in ring content, so a negative result in blood does not settle the
      question for cortex.
    proposed_experiments:
      - experiment_id: exp_r20_brain_versus_blood_ring_content
        name: Ring content and expression in brain versus blood from the same individuals
        description: >-
          Single-cell karyotype-informed sequencing and transcriptome profiling of
          postmortem or surgically obtained cortical tissue alongside matched blood
          from ring 20 donors, comparing ring fraction and gene expression between
          the two tissues.
        decision_criterion: >-
          A substantially higher cortical than blood ring fraction, or a cortical
          expression signature absent from blood, would show that blood-based
          negative studies were underpowered by tissue choice rather than wrong in
          principle. Matching ring fractions and expression would strengthen the
          case that the mechanism is not transcriptional at all.
      - experiment_id: exp_r20_nuclear_architecture_profiling
        name: Nuclear architecture profiling of ring versus rod chromosome 20
        description: >-
          Chromosome conformation capture and lamina-association mapping in
          patient-derived neurons carrying the ring, comparing the ring-bearing
          and normal cell lines from the same mosaic individual, which provides an
          internally controlled comparison.
        decision_criterion: >-
          Reproducible differences in chromosome 20 compartment or lamina
          association between the ring-bearing and normal lines of the same patient
          would support a nuclear architecture mechanism. Indistinguishable
          architecture would push the field toward instability-based accounts.
    evidence:
      - reference: PMID:22406087
        reference_title: Ring chromosome 20.
        supports: REFUTE
        evidence_source: OTHER
        snippet: >-
          While the underlying etiology of the phenotype is still not understood,
          evidence is accumulating which suggests the deletion of candidate genes
          on chromosome 20 is not responsible.
        explanation: >-
          Refutes the candidate-gene deletion hypothesis, which is why no genetic
          section names CHRNA4 or any other chromosome 20 gene as causal.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: REFUTE
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Enrichment analysis of SEM did not show any suggestive or highly shared
          epigenetic signature on either chromosome 20 or other chromosomes. No
          differences in methylation levels were found in the two main candidate
          genes CHRNA4 and KCNQ2.
        explanation: >-
          Refutes the epigenetic-silencing hypothesis, the third concrete candidate
          mechanism, using a genome-wide methylation screen designed to test it.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          However, given the relatively low coverage of subtelomeric regions on the
          450K array, a refinement of the analysis by a custom-targeted methylation
          assay may be necessary to exclude epigenetic silencing of the genes
          located in the p and q subtelomeric regions in r(20) patients.
        explanation: >-
          The authors' own limitation on that negative result. Marked PARTIAL
          because it means the silencing hypothesis is disfavoured rather than
          excluded, and it names the assay that would settle it.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: REFUTE
        evidence_source: OTHER
        snippet: >-
          In addition, patients carrying terminal deletions of the short or long
          arm of a linear chromosome 20 do not show the same epilepsy of r(20)
          syndrome patients
        explanation: >-
          The cleanest single argument against the gene-dosage account: losing the
          same material without forming a ring does not produce the disease, so the
          ring is contributing something the deletion does not.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Our retrospective literature analysis shows that only 12 out of 35
          patients who were evaluated had secondary aberrations in more than 5% of
          the cells
        explanation: >-
          Weighs against the dynamic-mosaicism hypothesis by showing r(20) is often
          not measurably unstable. Marked PARTIAL because the authors also note the
          secondary changes may partly be an in vitro artefact, which cuts the other
          way.
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          Moreover, non-supernumerary r(2) and r(4) patients do not exhibit
          epilepsy (56, 57), suggesting that the phenotype is likely dependent on
          the specific chromosome involved.
        explanation: >-
          Constrains any purely generic ring-instability account, since other rings
          formed the same way do not cause epilepsy. Whatever the mechanism is, it
          has to be chromosome 20 specific.
      - reference: PMID:33207017
        reference_title: Transcriptome analysis of a ring chromosome 20 patient cohort.
        supports: REFUTE
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Our findings nevertheless suggest that peritelomeric altered
          transcription is not the likely pathogenic mechanism in ring 20.
        explanation: >-
          Refutes the position-effect hypothesis directly, from a study designed to
          test it.
      - reference: PMID:33207017
        reference_title: Transcriptome analysis of a ring chromosome 20 patient cohort.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Geographic analysis did not identify altered expression in peritelomeric
          or other specific chromosome 20 regions.
        explanation: >-
          The primary negative result underlying that refutation.
      - reference: PMID:33207017
        reference_title: Transcriptome analysis of a ring chromosome 20 patient cohort.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Underlying genetic mechanisms are likely complex and may involve
          differential expression of many genes, the majority of which may not be
          located on chromosome 20.
        explanation: >-
          States the surviving distributed-mechanism hypothesis that the proposed
          experiments are designed to probe.
      - reference: PMID:28127864
        reference_title: >-
          Continuing role for classical cytogenetics: Case report of a boy with
          ring syndrome caused by complete ring chromosome 4 and review of
          literature.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Ring syndrome is thought to be caused by "dynamic mosaicism" due to ring
          instability.
        explanation: >-
          States the surviving instability hypothesis. Marked PARTIAL because it is
          asserted for ring syndromes in general, in a ring chromosome 4 case, and
          has not been demonstrated for the ring 20 epilepsy.
  - discussion_id: r20_is_the_rhythmic_pattern_ictal
    kind: CONTROVERSY
    status: OPEN
    prompt: >-
      Is the long-lasting rhythmic slow-wave pattern of ring 20 genuinely
      nonconvulsive status epilepticus, or an encephalopathic rhythm that is not
      itself seizure activity, and should it therefore be treated aggressively?
    attaches_to:
      - pathophysiology#Prolonged Nonconvulsive Status Epilepticus
      - pathophysiology#Frontally Predominant Cortical Hyperexcitability
    rationale: >-
      The pattern is called ictal by convention, but several features sit awkwardly
      with that reading. It can persist for days, far beyond what status epilepticus
      usually means. Its spike content is sparse, and a direct comparison found that
      ring 20 patients in nonconvulsive status had a less prominent spike component
      than patients in nonconvulsive status without the ring. Patients often remain
      partly responsive during it, sometimes answering questions, and in one
      reported pair daily activities were minimally affected while the discharges
      continued. Most telling, oral medication reduced the overt focal seizures by
      more than three quarters in those patients while leaving the electrical
      pattern entirely unchanged, a dissociation that would be surprising if the
      two shared a generator. The authors of that report state plainly that the
      mechanism of the continuous rhythmic waves may be unrelated to epilepsy. The
      opposing evidence is also real: the pattern accompanies confusional states
      that patients and families recognize as events, it is closely associated with
      cognitive decline in longitudinal series, and the current consensus treats it
      as status and recommends aggressive detection. The stake is direct and
      clinical. If it is status, prolonged episodes justify escalating treatment and
      possibly anaesthesia; if it is an encephalopathic rhythm, that escalation
      carries risk with no benefit, and the target of treatment should be the overt
      seizures instead.
    proposed_experiments:
      - experiment_id: exp_r20_metabolic_imaging_during_rhythmic_pattern
        name: Metabolic and cerebral blood flow imaging during the rhythmic pattern
        description: >-
          Ictal-interictal comparison using perfusion or metabolic imaging acquired
          during a prolonged rhythmic slow-wave episode and again in the same
          patient at baseline, testing whether the pattern is accompanied by the
          regional hypermetabolism and hyperperfusion that characterize genuine
          ictal activity.
        decision_criterion: >-
          Focal or regional hypermetabolism time-locked to the pattern would
          support a true ictal process and justify aggressive treatment. Absent or
          reduced metabolic change would support the encephalopathic-rhythm reading
          and argue against escalation.
      - experiment_id: exp_r20_cognitive_timelock_during_pattern
        name: Time-locked cognitive testing during and between rhythmic episodes
        description: >-
          Standardized within-patient cognitive testing performed during the
          rhythmic pattern and during matched pattern-free periods, quantifying
          whether measurable performance falls while the pattern is running.
        decision_criterion: >-
          A reproducible performance drop during the pattern would establish it as
          functionally disabling regardless of its label. Preserved performance
          would show the pattern is electrographic in a strong sense and would
          shift the treatment target to the overt seizures.
    evidence:
      - reference: PMID:16128150
        reference_title: >-
          Ring chromosome 20 with nonconvulsive status epilepticus:
          electroclinical correlation of a rare epileptic syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The electroclinical correlations in our cases raise the possibility that
          the mechanism of continuous rhythmic waves in this syndrome may be
          unrelated to epilepsy.
        explanation: >-
          States the sceptical position explicitly.
      - reference: PMID:16128150
        reference_title: >-
          Ring chromosome 20 with nonconvulsive status epilepticus:
          electroclinical correlation of a rare epileptic syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Despite the continuous discharges, the patients had relatively subtle
          clinical episodes of seizures, during which they were sometimes
          responsive to verbal stimuli.
        explanation: >-
          Documents the preserved responsiveness that is hard to reconcile with
          ongoing status epilepticus.
      - reference: PMID:16128150
        reference_title: >-
          Ring chromosome 20 with nonconvulsive status epilepticus:
          electroclinical correlation of a rare epileptic syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Oral AEDs decreased more than 75% of the overt CPS episodes in both
          patients at 22 and 26 months of follow-up but had no effect on the
          natural history of electrical NCSE.
        explanation: >-
          Documents the pharmacological dissociation between the overt seizures and
          the electrical pattern.
      - reference: PMID:9217679
        reference_title: >-
          Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic
          syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          the group with the chromosomal anomaly had more frequent, comparatively
          brief episodes of confusion associated with a less prominent spike
          component on the EEG
        explanation: >-
          The controlled comparison showing that the ring 20 pattern differs
          electrographically from ordinary nonconvulsive status, which is part of
          what raises the question.
      - reference: PMID:42096279
        reference_title: >-
          Management of ring chromosome 20 syndrome: Narrative review and
          consensus recommendations.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          as there is a high incidence of non-convulsive status epilepticus
          (NCSE), there should be a low threshold for video-EEG monitoring if
          patients have a change in behavior or level of consciousness
        explanation: >-
          Represents the prevailing position, that the pattern is status and should
          be actively sought. Marked PARTIAL because it is a consensus
          recommendation rather than evidence bearing on whether the pattern is
          ictal.
  - discussion_id: r20_encephalopathy_versus_parallel_effect
    kind: CONTROVERSY
    status: OPEN
    prompt: >-
      Is the intellectual disability of ring 20 caused by the epilepsy, making this
      a true developmental and epileptic encephalopathy, or is it a parallel
      consequence of carrying the ring that would occur regardless of seizure
      control?
    attaches_to:
      - pathophysiology#Cognitive Decline and Behavioural Disturbance
      - pathophysiology#Prolonged Nonconvulsive Status Epilepticus
    rationale: >-
      The encephalopathy reading rests on a genuinely striking observation:
      children develop normally and only then lose ground, with intellectual
      disability manifesting after seizure onset. It is reinforced by the finding
      that earlier seizure onset predicts worse cognitive outcome. But the
      correlation is confounded, because a higher ring ratio predicts both earlier
      seizure onset and worse cognition, so seizure timing may be a marker of ring
      burden rather than the cause of the cognitive outcome. Two further
      observations cut against the pure encephalopathy account. Behavioural
      disturbance has been reported to begin before the first seizure in a
      substantial minority, which no seizure-driven mechanism can explain. And
      adolescent-onset patients had a milder developmental course with no cognitive
      decline despite having both dyscognitive seizures and nonconvulsive status,
      suggesting the vulnerable window matters more than seizure burden. The
      question is not academic: if the epilepsy drives the cognitive outcome, then
      aggressive early seizure control is cognitively protective and worth its side
      effects, whereas if cognition tracks ring burden independently, that
      aggressive approach buys less than it appears to and families deserve to know
      that.
    proposed_experiments:
      - experiment_id: exp_r20_ring_ratio_adjusted_cognitive_modeling
        name: Ring-ratio-adjusted modeling of cognitive outcome in a multicentre cohort
        description: >-
          Pooled multicentre longitudinal cohort with ring ratio, age at seizure
          onset, seizure and status burden, and serial standardized cognitive
          testing, modeling cognitive trajectory with ring ratio and seizure burden
          entered as separate predictors rather than examined pairwise.
        decision_criterion: >-
          An independent effect of seizure and status burden after adjustment for
          ring ratio would support the encephalopathy model. Cognitive outcome
          explained by ring ratio alone, with seizure burden adding nothing, would
          support the parallel-effect model.
      - experiment_id: exp_r20_prospective_preseizure_developmental_assessment
        name: Prospective developmental assessment of ring carriers before seizure onset
        description: >-
          Systematic developmental and behavioural assessment of individuals found
          to carry a ring 20 before epilepsy has begun, including relatives and
          incidental findings, establishing whether measurable deficits precede the
          first seizure.
        decision_criterion: >-
          Detectable pre-seizure developmental or behavioural deviation would show
          part of the phenotype is seizure-independent. Genuinely normal
          pre-seizure development across a series would strengthen the
          encephalopathy model.
    evidence:
      - reference: PMID:33363513
        reference_title: >-
          Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and
          Overlapping Phenotypes.
        supports: SUPPORT
        evidence_source: OTHER
        snippet: >-
          intellectual disability manifesting after seizure onset in otherwise
          normally developing children
        explanation: >-
          The core observation supporting the encephalopathy reading.
      - reference: PMID:22424860
        reference_title: >-
          Ring chromosome 20 syndrome: electroclinical description of six patients
          and review of the literature.
        supports: REFUTE
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          There were three patients out of six with behavioral disturbances before
          the onset of seizures.
        explanation: >-
          Refutes the claim that the whole neurobehavioural phenotype follows the
          seizures, since half of this series showed disturbance beforehand.
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          The r(20) ratio and severity of cognitive impairment appear to be
          directly related to each other and inversely correlated with the age at
          epilepsy onset.
        explanation: >-
          Documents the three-way correlation that makes seizure onset age and ring
          ratio impossible to separate without adjusted modeling, which is the
          confound this discussion turns on.
      - reference: PMID:27816898
        reference_title: Epilepsy in ring chromosome 20 syndrome.
        supports: SUPPORT
        evidence_source: HUMAN_CLINICAL
        snippet: >-
          Epilepsy onset in adolescence (3 patients) was accompanied by a milder
          developmental course, dyscognitive seizures and non-convulsive status
          epilepticus, and no cognitive decline.
        explanation: >-
          Shows that nonconvulsive status can occur without cognitive decline when
          onset is later, which argues that the developmental window matters
          independently of seizure burden.

📚

References & Deep Research

References

3

PMID:22406087

Ring chromosome 20.

No top-level findings curated for this source.

PMID:33363513

Ring Chromosome 20 Syndrome: Genetics, Clinical Characteristics, and Overlapping Phenotypes.

No top-level findings curated for this source.

PMID:42096279

Management of ring chromosome 20 syndrome: Narrative review and consensus recommendations.

No top-level findings curated for this source.

Deep Research

1

Claude Code ▸

Ring Chromosome 20 Syndrome — Disease Characteristics Research Report

claude-haiku-4-5-20251001, claude-opus-5[1m] 24 citations 2026-08-05T13:13:54.701835

Ring Chromosome 20 Syndrome — Disease Characteristics Research Report

Compiled 2026-08-05. Target: dismech KB entry (MONDO:0015436).

0. Executive framing

Ring chromosome 20 is the weird one in the chromosomal-disorder cabinet. Almost every other ring/aneuploidy syndrome announces itself with a face — dysmorphic features, growth failure, birth defects. r(20) mostly doesn't. Kids develop normally, look ordinary, and then somewhere around age 6–7 the electrical weather over the frontal lobes changes permanently. It's the syndrome that hides from the very tests we've replaced karyotyping with: if the ring is "complete" (no genetic material lost), microarray, gene panels, and exome/genome sequencing all come back normal. You only see it if you actually look at the chromosomes under a microscope, and only if you count enough cells.

That fact — pathology without measurable gene loss — is the whole mechanistic puzzle, and honestly the most defensible way to model it is unknown mechanism with several competing hypotheses, which is exactly how the recent literature treats it.

1. Disease Information

Overview

Ring chromosome 20 syndrome (r(20)) is a rare chromosomal disorder in which one copy of chromosome 20 is circularized by fusion of its short (p) and long (q) arms, usually at p13 and q13.33. It presents as a developmental and epileptic encephalopathy (DEE): childhood-onset, drug-resistant focal epilepsy with a highly characteristic pattern of recurrent non-convulsive status epilepticus (NCSE), cognitive decline that typically follows rather than precedes seizure onset, and behavioral/psychiatric disturbance — in the usual absence of dysmorphism, malformations, or growth abnormality.

Khamis et al. 2026 (verbatim, read directly):

"Ring chromosome 20 (ring 20) is a rare genetic condition usually presenting as developmental and epileptic encephalopathy. The disease is caused by fusion of the long and short arms of chromosome 20. Patients are symptomatic even if there is no loss of genetic material." — Khamis A, Ricci E, Canevini MP, Lagae L, Tokumoto K, Inoue Y, Buckinx T, Watson A, Myers KA. Management of ring chromosome 20 syndrome: Narrative review and consensus recommendations. Epilepsia 2026;00:1–11. PMID:42096279; DOI:10.1002/epi.70266 (open access).

First described in 1972 (Atkins, Miller & Salam, J Med Genet 9:377–80); established as a distinct epileptic syndrome by Inoue et al. 1997 (PMID:9217679, Brain 120:939–53).

Key identifiers

Resource	ID	Notes
MONDO	MONDO:0015436	label `ring chromosome 20`
Orphanet	ORPHA:1444	MONDO xref
UMLS	C0265482
MeSH	C580424	supplementary concept, not a MeSH descriptor
DOID	DOID:0070622
GARD	0001334
MedGen	489853
NCIT	NCIT:C169001
SNOMED CT	23686004
ICD-9-CM	758.89	via MONDO xref
ICD-10	Q93.2 (conventional)	"Chromosome replaced with ring, dicentric or isochromosome" — coding convention, not an r(20)-specific MONDO mapping; flag as approximate
OMIM	none	No dedicated OMIM phenotype entry — it's a cytogenetic entity, not a Mendelian locus. Do not invent one.

MONDO definition (verbatim from OLS4):

"Ring chromosome 20 syndrome is marked by a characteristic seizure phenotype. Depending on the amount of chromosomal loss and associated mosaicism, ring(20) can be associated with macrocephaly, mild to moderate intellectual deficit, or behavioral problems. In rare cases, brain, kidney or heart malformations may be present."

(Curator note: that MONDO definition's "macrocephaly" is an outlier claim — the primary literature more often reports microcephaly in the minority with dysmorphism (Khamis 2026). Don't propagate macrocephaly as a phenotype without a real citation.)

Synonyms

ring chromosome 20 syndrome (exact); R20 (abbreviation); ring 20, ring 20 syndrome, r(20) syndrome, chromosome 20 ring, ring chromosome type 20, ring chromosome 20 epilepsy syndrome (related). ISCN karyotype string: 46,XX,r(20)(p13q13.3)[n]/46,XX[m].

Data provenance

Everything here is aggregated disease-level — case reports, case series, two retrospective cohorts, one cross-sectional caregiver survey, and two systematic reviews. There is no registry, no natural-history study, and no randomized trial. Khamis 2026 Table 1 counted, across their whole literature base: 19 case reports, 11 case series, 2 cohort studies, 1 cross-sectional survey, 1 meta-analysis, 1 molecular study — 0 open-label prospective clinical trials and 0 randomized clinical trials. A ClinicalTrials.gov query for "ring chromosome 20" returns no r(20) studies at all (checked 2026-08-05; only an unrelated vaginal-ring PK study, NCT02092571).

2. Etiology

2.1 Causal factor — the ring itself

The disorder is caused by a structural chromosomal rearrangement, not a sequence variant. Chromosome 20 breaks near both telomeric ends and the broken ends join, producing a circular chromosome that replaces one normal chromosome 20 (non-supernumerary).

Two mechanistically distinct routes exist, and Conlin et al. 2011 (PMID:20972251, J Med Genet 48:1–9) is the paper that split them apart. In 28 patients:

Mosaic group (n=21) — ring formed by post-zygotic telomere–telomere fusion, subtelomeric and telomeric sequences intact, no detectable deletion. Mean seizure onset ~6.0 years.
Non-mosaic group (n=7) — ring formed by break-and-fusion, typically in meiosis/gametogenesis, with terminal deletions of variable size on 20p and/or 20q. Mean seizure onset ~2.1 years, "more extensive comorbidities."

Conclusion reported: ring chromosome 20 is "molecularly heterogeneous and formed by two distinct mechanisms."

Peron et al. 2020 (PMID:33363513, Front Neurol 11:613035) reinforces this split: >150 reported mosaic cases vs 26 non-mosaic; in mosaic cases "the r(20) maintained intact subtelomeric and telomeric sequences, and no genomic imbalances of the chromosome were detected"; ~50 individuals tested by chromosomal microarray showed no detectable deletion or duplication.

2.2 Genetic risk factors

Causal lesion: the r(20) itself. GENO framing: structural variant / chromosomal rearrangement, almost always de novo.
Candidate genes in the deleted subtelomeric interval (non-mosaic cases only):
CHRNA4 (20q13.33, ~1 Mb from telomere; hgnc:1960) — autosomal dominant nocturnal frontal lobe epilepsy, OMIM #600513
KCNQ2 (20q13.33, ~1 Mb from telomere; hgnc:6296) — benign familial neonatal epilepsy / KCNQ2-DEE, OMIM #602235
DNAJC5 (20q13.33, ~450 kb from telomere; hgnc:16235) — adult-onset neuronal ceroid lipofuscinosis
The deletion hypothesis is largely refuted as a general explanation. Peron 2020: "Deletions in r(20) have been detected only in few affected individuals with different breakpoints, not always including CHRNA4, KCNQ2, DNAJC5, or other genes on 20q13.3." Elghezal et al. 2007 (PMID:17851150) reported a typical r(20) epilepsy phenotype with metaphase FISH showing no deletion at all, including intact CHRNA4 and KCNQ2 loci. Zou et al. 2006 (PMID:16835934) likewise: mosaic ring 20, characteristic seizure disorder, no detectable subtelomeric loss by FISH.
Contrapositive evidence: Villéga et al. 2011 (PMID:21397468) described a child with a 20p13 telomeric deletion and no epilepsy, arguing the epilepsy signal lives on the 20q side (or not in gene dosage at all): "Preservation of CHRNA4 and KCNQ2 gene activity could explain this distinctive feature."
Uniparental disomy (UPD) has been excluded by molecular analysis in r(20) patients (Peron 2020).
Modifier genes: none identified. The single strongest quantitative modifier of phenotype is not a gene at all — it's the percentage of cells carrying the ring (see §9).

2.3 Environmental risk factors

None identified. No toxin, infection, radiation, drug exposure, parental-age effect, or lifestyle factor has been associated with r(20) formation. Advanced parental age has not been implicated. This section is genuinely empty and should be curated as such rather than padded.

2.4 Protective factors

None identified, genetic or environmental. The nearest thing to a protective factor is low ring mosaicism, which is a dosage property of the lesion rather than a protective allele (Tokumoto 2025, PMID:40119828: lower mosaicism rate independently associated with favorable seizure outcome).

2.5 Gene–environment interactions

No documented GxE. Two clinically important state-dependent modulators of seizure expression are worth noting as candidate "environmental" triggers at the physiological level: - Sleep/state: seizures are strongly nocturnal/sleep-related; a 2025 case report (PMID:40881175) documented NCSE forming a CSWS-like continuous spike-wave pattern in NREM with "near-complete resolution of epileptiform abnormalities" at REM onset, and reported reduced NCSE frequency after melatonin 4 mg/day. - Praxis induction: reflex seizures induced by praxis (thinking/manipulation tasks) reported in two Japanese cases (Yamagishi et al., Epileptic Disord 2020;2:214–8, cited in Khamis 2026).

3. Phenotypes

3.1 Core electroclinical phenotype

Best current frequency data come from the 2026 systematic review — Brenton L, Komar M, Ramachandran Nair R, Cunningham J, Sharma S, Balci T, Myers KA, Jain P, Whitney R. Delineating the epilepsy phenotype of ring chromosome 20: A systematic literature review. PMID:42468067, Epilepsy Res 2026;227:107874 — 71 studies, 192 patients:

Feature	Frequency	HPO suggestion (label verified via OAK)
Non-convulsive status epilepticus	88%	`HP:0032671` Non-convulsive status epilepticus without coma (preferred); parent `HP:0002133` Status epilepticus
Ictal fear / terror	72%	`HP:0032752` Focal impaired awareness emotional seizure with fear/anxiety/panic, or `HP:0032739` Focal emotional seizure with fear/anxiety/panic
Focal seizures with impaired awareness (most common single type)	50.3%	`HP:0002384` Focal impaired awareness seizure
Drug-resistant epilepsy	80%	`HP:0007359` Focal-onset seizure + modifier `HP:0031375` Refractory
Median age at seizure onset	7 years	onset descriptor: childhood

Cross-check from the 47-patient Japanese cohort (Tokumoto K, Nishida T, Ikeda H, Ikeda H, Kawaguchi N, Mizutani S, et al. Long-term seizure and psychosocial outcomes of patients with ring chromosome 20 syndrome: a cohort study of 47 cases. PMID:40119828, Epilepsia 2025;66(7):2444–53):

64% female; mean age at epilepsy onset 7.5 ± 3.7 y
median ring mosaicism 33% ± 24% (range 1–97%)
mean IQ 66.4 ± 16.0
intellectual disability 57.4% (27/47)
autism spectrum disorder 17.0% (8/47)
psychiatric symptoms 21.3% (10/47)
~30% achieved seizures "minimally disruptive to daily life"

And Peron 2020 (PMID:33363513) for the qualitative core:

"Ring chromosome 20 syndrome in mosaic patients is characterized by a distinctive and recognizable epileptic phenotype and frequent—but not universal—cognitive decline and behavioral problems following seizure onset."

3.2 Seizure semiology (three recurring types, per Peron 2020)

Nocturnal hyperkinetic/hypermotor seizures — "waking up, staring, and mild tonic stiffening evolving into clonic movements of the face and of the extremities, followed by agitation and confusion." → HP:0011174 Focal hyperkinetic seizure; HP:0032726 Focal impaired awareness hyperkinetic seizure
Subtle nocturnal seizures — "minimal motor activity, such as subtle stretching, turning, or rubbing movements." (These are chronically missed; parents call them restlessness.)
Focal seizures with impaired awareness — "unresponsiveness, staring and confusion, with or without oral or motor automatisms, frightened expression, and focal motor symptoms." → HP:0002384; HP:0011153 Focal motor seizure

Secondary bilateral tonic-clonic seizures are comparatively rare in r(20) (HP:0002069 Bilateral tonic-clonic seizure — curate as infrequent, not typical).

3.3 Non-convulsive status epilepticus — the signature

Peron 2020:

"One of the key manifestations of r(20) syndrome. It consists of a prolonged confusional state of variable intensity and duration, associated with long-lasting slow waves with occasional spikes usually predominant over the frontal regions." "The particularity of r(20) is the recurrence of NCSE: patients with r(20) experience very frequent NCSE, which can present even daily."

Two consequences worth encoding in the KB as clinically load-bearing: - NCSE in r(20) is routinely misread as psychiatric illness for years or decades. A 2025 report (PMID:41210661) describes a 42-year-old woman whose "prolonged psychiatric symptoms" were finally shown by video-EEG to be NCSE — seizures had begun at age 6, and the psychiatric misinterpretation persisted for decades. - r(20) dominates the genetics of atypical absence status epilepticus. A 2026 systematic review of AASE (PMID:42112912, Epilepsia Open) found: "Most patients had a chromosomal abnormality (88%), in particular ring chromosome 20 (53% of the total patients) and Angelman syndrome caused by a 15q11-q13 deletion (31%)." → also HP:0011151 Atypical absence status epilepticus.

3.4 Ictal fear and hallucinations

Peron 2020 reports children with r(20) "can experience terrific hallucinations even before the clear onset of their seizures," never recorded in the absence of seizure activity, and classifies them as "ictal fear as a possible symptom of frontal lobe seizures that involve the limbic system." Vignoli 2016 (PMID:27816898, 25 patients) describes "terrifying hallucinations" in the childhood-onset group. → HP:0000738 Hallucinations; HP:0002367 Visual hallucination; HP:0012007 Focal cognitive seizure with hallucination.

3.5 Cognitive and behavioral phenotype

Development is normal before seizure onset in ~85%. Khamis 2026 (verbatim): "Prior to epilepsy onset, abnormal development is reported in only ~15%; however, development regression or plateau may occur in concert with the appearance of seizures, in keeping with a developmental and epileptic encephalopathy (DEE)."
Post-onset: Peron 2020 — "Speech and executive abilities are frequently affected, resulting in apathy or hyperactivity, loss of social skills, obsessive behavior, psychosis, and autistic features."
Khamis 2026 catalogue of comorbidity (verbatim): "language deficits, disorientation, apathy, agitation, hyperphagia, pica, loss of emotional facial expression, cognitive slowing, aggression, reckless behavior, impairment in adaptive behavior and social skills, motor skills deficits, executive dysfunction, obsessive-compulsive traits, and autism."

HPO suggestions (all labels OAK-verified): HP:0001249 Intellectual disability · HP:0002342 Moderate intellectual disability · HP:0001268 Mental deterioration · HP:0002376 Developmental regression · HP:0000750 Delayed speech and language development · HP:0000717 Autism · HP:0007018 Attention deficit hyperactivity disorder · HP:0000752 Hyperactivity · HP:0000718 Aggressive behavior · HP:0000709 Psychosis · HP:0002360 Sleep disturbance

3.6 Physical phenotype (mostly absent — this is diagnostically load-bearing)

Peron 2020:

"Most patients with r(20) syndrome are otherwise healthy. Unlike other chromosomal abnormalities, r(20) individuals usually have normal pre- and post-natal growth parameters, and do not exhibit a distinctive facial appearance."

Khamis 2026 (verbatim) on the minority who do have features:

"Dysmorphic features have been reported in a minority of people with ring 20; when present, these are usually subtle, with described features including microcephaly, dental malocclusions, and cauliflower-shaped ears."

→ HP:0000252 Microcephaly (minority, chiefly non-mosaic) · HP:0000689 Dental malocclusion. Brain/kidney/heart malformations are listed by Orphanet/MONDO as rare; treat as VERY_RARE and cite carefully.

3.7 Age-dependent phenotype gradient

Vignoli et al. 2016 (PMID:27816898, 25 patients) established an "age dependent course": - Early childhood onset → frequent nocturnal motor seizures, terrifying hallucinations, epileptic encephalopathy, NCSE, cognitive decline - Adolescent onset → milder: dyscognitive seizures and NCSE, but without cognitive decline - "statistically significant correlations between age at epilepsy onset and cognitive level"

3.8 Quality of life

Hard psychosocial outcomes from Tokumoto 2025 (adults, n=30) are the best QoL proxy available: - employed 23.3% - living with family 83.3% - married 6.7% - holds a driver's license 3.3%

Caregiver burden is separately documented as a major disease dimension (Watson A, Watson D, Taylor JP. Life with r(20) — ring chromosome 20 syndrome. Epilepsia 2015;56:356–8; Schiller K, et al. Sociocultural factors influence on burden and stress of caregivers of children with epilepsy. Can J Neurol Sci 2025;52(2):322–6). Khamis 2026 (verbatim): "Caregivers of people with ring 20 have expressed a need for support, and have noted that their neurology teams (particularly in adult care) are often unfamiliar with the disorder." Screening for caregiver burnout is one of the eight formal consensus recommendations.

4. Genetic / Molecular Information

4.1 Causal lesion

Type: constitutional structural chromosomal abnormality — ring chromosome, non-supernumerary, replacing one homolog of chromosome 20.
Breakpoints: typically 20p13 and 20q13.33.
Origin: germline (constitutional), de novo in essentially all cases; somatic mosaicism is the norm rather than the exception (post-zygotic ring formation).
Functional consequence: in non-mosaic/deleted cases — segmental haploinsufficiency of 20p and/or 20q terminal genes (loss of function). In mosaic/complete-ring cases — no measurable gene-dosage change; the functional consequence is unexplained (see §6).

4.2 Candidate genes (only relevant to the deleted subset)

Gene	HGNC	Locus	Distance from telomere	Disease association
CHRNA4	`hgnc:1960`	20q13.33	~1 Mb	ADNFLE, OMIM #600513
KCNQ2	`hgnc:6296`	20q13.33	~1 Mb	BFNE / KCNQ2-DEE, OMIM #602235
DNAJC5	`hgnc:16235`	20q13.33	~450 kb	adult-onset NCL

(Verify HGNC numeric IDs against the local adapter before writing them into YAML — I did not OAK-check these three.)

Variant classification / allele frequency / somatic-vs-germline sections are not applicable in the usual ACMG sense: there is no SNV, and gnomAD/ClinVar carry no r(20) allele frequency. ClinVar/DECIPHER may hold 20p13 and 20q13.33 terminal deletion records relevant to the non-mosaic subset.

4.3 Epigenetics

Telomere position effect (TPE) is the leading epigenetic hypothesis. Peron 2020: "Telomeric chromatin marks can spread and repress gene expression up to 100 kb from the telomere itself with a more pronounced effect when telomeres are long."
Directly tested and not supported so far. Peron 2020's methylation array analysis found "no differences in methylation levels…in the two main candidate genes CHRNA4 and KCNQ2," though they note higher-resolution targeted subtelomeric assays are still needed.

4.4 Transcriptomics — the key negative result

Myers KA, Bennett MF, Hildebrand MS, Coleman MJ, Zhou G, Hollingsworth G, Cairns A, Riney K, Berkovic SF, Bahlo M, Scheffer IE. Transcriptome analysis of a ring chromosome 20 patient cohort. PMID:33207017, Epilepsia 2021;62(1):e22–e28.

RNA-seq on 7 r(20) patients and 11 first-degree relatives. 97 genes showed potential differential expression, but the conclusion was blunt: "peritelomeric altered transcription is not the likely pathogenic mechanism in ring 20", and "underlying genetic mechanisms are likely complex and may involve differential expression of many genes."

This is the single most important constraint on any mechanism model you write: the obvious peritelomeric-silencing story was tested in humans and did not hold up.

4.5 Chromosomal instability / dynamic mosaicism

Rings are mitotically unstable — sister chromatid exchange within a ring produces interlocked or dicentric rings, anaphase bridges, ring loss (→ monosomy 20 cells), and duplicated rings. Elghezal 2007 (PMID:17851150) quantified this in one patient: 70% r(20) / 30% normal on metaphase karyotype, with interphase FISH showing 7% monosomy 20 and 8% duplicated ring. Their proposal: "clinical features of ring chromosome 20 syndrome are caused by low mosaicism of chromosome 20 monosomy caused by the loss of the ring chromosome 20."

5. Environmental Information

Environmental factors: none known.
Lifestyle factors: none causal. Downstream, sleep deprivation and general seizure-precipitant hygiene apply as they do in any drug-resistant epilepsy; ketosis is an interventional rather than risk exposure (§12).
Infectious agents: not applicable.

Curate this section as explicitly negative — it's informative that a chromosomal DEE has no environmental etiology, and an empty section reads as missing data.

6. Mechanism / Pathophysiology

Here's the honest shape of it: the mechanism is unknown, and there are four live competing hypotheses plus one robust downstream network finding. I'd model this as a disease entry with mechanistic_hypotheses groups rather than a single canonical chain — anything else overstates the field.

6.1 The central paradox

Symptoms occur without loss of genetic material (Khamis 2026, verbatim, from the abstract). Any mechanism must explain how a topologically circular but sequence-complete chromosome causes a frontal-lobe epileptic encephalopathy.

6.2 Competing mechanistic hypotheses

H1 — Subtelomeric gene haploinsufficiency (CHRNA4/KCNQ2) — largely REFUTED as a general mechanism, retained for the non-mosaic subset. Deletions occur in a minority, with inconsistent breakpoints that don't always include the candidate genes (Peron 2020); typical phenotypes occur with no deletion by FISH (Elghezal 2007 PMID:17851150; Zou 2006 PMID:16835934); and 20p13 deletion without epilepsy has been reported (Villéga 2011 PMID:21397468). Still plausible as a contributor in non-mosaic deleted patients, whose phenotype is earlier and more severe (Conlin 2011 PMID:20972251). GO/CL anchors if you curate this arm: GO:0095500 acetylcholine receptor signaling pathway (CHRNA4), GO:0034765 regulation of monoatomic ion transmembrane transport and GO:0042391 regulation of membrane potential (KCNQ2/M-current), GO:0001508 action potential; cell types CL:0010012 cerebral cortex neuron, CL:0000679 glutamatergic neuron, CL:0000617 GABAergic neuron.

H2 — Telomere position effect / epigenetic silencing near the fusion point — NOT SUPPORTED to date. Mechanistically attractive (GO:0031507 heterochromatin formation; GO:0040029 epigenetic regulation of gene expression; GO:0010629 negative regulation of gene expression; GO:0000723 telomere maintenance), but methylation arrays showed no difference at candidate loci (Peron 2020) and the transcriptome study explicitly rejected peritelomeric altered transcription (Myers 2021 PMID:33207017).

H3 — Ring instability / dynamic somatic mosaicism ("ring syndrome" logic) — LIVE. Ongoing mitotic instability generates a shifting population of monosomy-20 and duplicated-ring cells, with associated cell death and growth disadvantage, producing tissue-level and possibly brain-region-level dosage chaos that no static assay captures (Elghezal 2007; Peron 2020). Anchors: GO:0007059 chromosome segregation, GO:0000819 sister chromatid segregation, GO:0051301 cell division, GO:0006915 apoptotic process.

H4 — Complex polygenic dysregulation across the ring / nuclear architecture — LIVE but untested. Myers 2021's own conclusion (many genes, complex mechanism). Peron 2020 proposes the experiment: iPSC-derived neuronal progenitors retaining a structurally complete ring, used to "map its position and folding within the nucleus using multiple methods to decode 3D chromosome architecture" — but notes the hard blocker: "the RC is lost early after reprogramming and before any iPSC-induced differentiation." Anchors: GO:0006325 chromatin organization.

Ruled out: uniparental disomy (Peron 2020).

6.3 The downstream network finding — basal ganglia / nigrostriatal seizure-control failure

This is the best-evidenced functional mechanism, and it's a lovely one: r(20) seizures are pathologically long, which points less at how seizures start and more at a failure of the brake that normally stops them. Think of it less like a faulty ignition and more like a broken vagal brake on a runaway heart — the pacemaker isn't the problem, the damping is.

Biraben A, Semah F, Ribeiro MJ, Douaud G, Remy P, Depaulis A. PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy. PMID:15249613, Neurology 2004. [¹⁸F]fluoro-L-DOPA PET in 14 r(20) patients vs 10 controls: "uptake was significantly decreased bilaterally in the putamen and in the caudate nucleus of patients. This reduction was equal for both nuclei and was not correlated to the percentage of cells with r(20)." Conclusion: "Striatal dopamine is modulated in r(20) epilepsy; dysfunction of this neurotransmission may impair the mechanisms that interrupt seizures."
Meletti S, et al. Ictal involvement of the nigrostriatal system in subtle seizures of ring chromosome 20 epilepsy. PMID:22738216, Epilepsia 2012. EEG-fMRI showed "ictal BOLD increments in a cortical-subcortical network involving substantia nigra–striatum and frontal cortex" — first functional imaging evidence of nigrostriatal involvement during ictal discharges in r(20).
Avanzini P, et al. Low frequency mu-like activity characterizes cortical rhythms in epilepsy due to ring chromosome 20. PMID:23968845, Clin Neurophysiol 2014. 12 r(20) patients vs 12 IGE and 12 healthy controls: a reproducible 3–7 Hz theta-delta rhythm whose generators mapped over sensorimotor cortices, absent in both control groups — "suggests a sensory-motor system dysfunction in [r(20)] patients."
Peron 2020 summarizes: "PET, SPECT, and fMRI data are consistent with the notion that r(20) syndrome is associated with dysfunction of the frontal lobe network…together with the basal ganglia."

Suggested causal chain for the KB (with the honest gap flagged at the top):

[UNKNOWN LINK — see mechanistic_hypotheses]
ring chromosome 20 formation (telomere fusion, ± terminal deletion)
  → mitotically unstable ring; dynamic somatic mosaicism (monosomy 20 / duplicated ring cells)
  → [MECHANISM UNRESOLVED: dosage vs epigenetic vs architectural]
  → frontocortical network hyperexcitability (E/I imbalance)
  → nigrostriatal / basal-ganglia seizure-termination failure (reduced striatal F-DOPA uptake)
  → abnormally prolonged focal seizures and recurrent NCSE
  → epileptic encephalopathy: cognitive decline, behavioral/psychiatric deterioration

Molecular pathways: no validated pathway. Candidate arms only — cholinergic (CHRNA4), M-current/K⁺ channel (KCNQ2), dopaminergic (GO:0001963 synaptic transmission, dopaminergic), GABAergic (GO:0007214 gamma-aminobutyric acid signaling pathway), general GO:0007268 chemical synaptic transmission.
Cellular processes: chromosome mis-segregation, apoptosis of aneuploid cells, altered neuronal excitability. No confirmed cell-type-specific mechanism.
Protein dysfunction: none demonstrated. Do not assert misfolding/aggregation.
Metabolic changes: none characterized (which is itself notable, given ketogenic therapy is used empirically). Metabolic workup is described as unrevealing.
Immune involvement: none. Relevant only as a differential — anti-NMDAR encephalitis (Peron 2020) — and as an unproven therapy (steroids, IVIg; §12).
Tissue damage: no structural neuropathology. Conventional brain MRI is typically normal (Peron 2020).
Single-cell / spatial / multi-omics: none published for r(20). Genuine gap.
Functional genomics screens: none.

Curator recommendation: this entry is a strong candidate for discussions with kind: KNOWLEDGE_GAP on the core mechanism, plus a HUMAN_MODEL_MISMATCH note on the iPSC problem (the ring is lost during reprogramming, so the only obvious human cellular model erases the very lesion you want to study). Khamis 2026 says it outright (verbatim): "a better understanding of the underlying pathophysiology of ring 20 is necessary to facilitate the development of precision therapies… The development of in vivo and in vitro models, as well as disease biomarkers, is essential."

7. Anatomical Structures Affected

Organ level - Primary: brain (UBERON:0000955), specifically the frontal lobe (UBERON:0016525) network — this is a frontal-lobe epilepsy syndrome both semiologically and electrographically. - Subcortical: basal ganglion (UBERON:0002420), striatum (UBERON:0002435), putamen (UBERON:0001874), caudate nucleus (UBERON:0001873), substantia nigra (UBERON:0002038) — implicated by F-DOPA PET (PMID:15249613) and EEG-fMRI (PMID:22738216). - Also implicated: cerebral cortex (UBERON:0000956) sensorimotor regions (PMID:23968845). - Secondary organ involvement: none typical. Brain/kidney/heart malformations are listed as rare by Orphanet/MONDO; treat as very rare and cite carefully. - Body systems: nervous system only, in the vast majority.

Lateralization: bilateral / diffuse. The PET reduction was "significantly decreased bilaterally"; ictal EEG shows bilateral frontally-dominant slow activity. This bilaterality is exactly why it is not a resective-surgery candidate.

Tissue and cell level: no validated cell-type-specific lesion. Reasonable descriptors if you need them: CL:0000540 neuron, CL:0010012 cerebral cortex neuron, CL:0000679 glutamatergic neuron, CL:0000617 GABAergic neuron, CL:0000700 dopaminergic neuron (nigrostriatal arm), CL:0000598 pyramidal neuron. Flag all as inferred, not demonstrated — there is no r(20) neuropathology series.

Subcellular level: the affected compartment is, unusually, the nucleus/chromosome itself — GO cellular component GO:0005634 nucleus, GO:0005694 chromosome (verify IDs before use; I did not OAK-check these two).

8. Temporal Development

Onset - Congenital lesion, childhood-onset disease. The ring is present from conception/early embryogenesis; the phenotype declares itself with seizures. - Median/mean age at seizure onset: 7 years (systematic review, PMID:42468067); 7.5 ± 3.7 y (cohort, PMID:40119828); mean ~7 y with sex difference (8 y F, 6 y M) in Peron 2020. Most before age 10. - Non-mosaic patients present much earlier — mean 2.1 y vs 6.0 y (Conlin 2011, PMID:20972251). - Range extends to infancy in high-mosaicism cases and to adolescence in low-mosaicism cases. - Onset pattern: subacute, and frequently retrospectively recognized — the earliest events (subtle nocturnal seizures, night terrors, "hallucinations") are usually misattributed for months to years.

Progression - Course: chronic, lifelong, drug-resistant in ~80% (PMID:42468067). Khamis 2026 recommends families be counseled that "seizures are likely to be drug-resistant and life-long" — and, notably, this is one of only two recommendations they graded quality of evidence "high". - Encephalopathic phase: developmental plateau or regression coincident with seizure onset; cognitive/behavioral decline accrues thereafter, in keeping with DEE. - Rate: variable, and predicted by (a) age at onset and (b) ring mosaicism percentage. - No recognized end-stage or terminal phase. It is not a neurodegenerative disorder in the classical sense.

Patterns - Remission: spontaneous remission is not described. Treatment-associated improvement occurs — ~30% of the 47-case cohort reached "minimally disruptive" seizures (PMID:40119828); Peron 2020 identifies "a group with favorable outcome (no seizures, with or without medications)" alongside the refractory group. Some anecdotal reports describe improvement with age in low-mosaicism adolescents. - Fluctuating/episodic overlay: NCSE episodes recur, sometimes daily, with "waxing and waning intensity" — the day-to-day picture fluctuates far more than the underlying trajectory. - Critical periods: the peri-onset window is the intervention target — Gordon 2020 (PMID:32524055) argues "Nonpharmacological treatments alongside antiepileptic drugs early after diagnosis may help reduce seizure frequency and preserve cognition." Adolescent transition to adult care is a second flagged vulnerable window (Khamis 2026, §3.2.1).

9. Inheritance and Population

Epidemiology

Prevalence and incidence: unknown. Khamis 2026 (verbatim): "The first patients with ring 20 were described in 1972, and fewer than 200 individuals have since been reported in the literature; incidence and prevalence are unknown, but unsuccessful attempts at estimation indicate that it is an ultra-rare condition."
MedlinePlus Genetics: rare, prevalence unknown, "more than 200 affected individuals" documented globally.
Barbour K, Tian N, Yozawitz EG, Wolf S, McGoldrick PE, Sands TT, et al. Population-based study of rare epilepsy incidence in a US urban population. PMID:38795333, Epilepsia 2024;65(8):2341–51 — the NYC 2010–2014 population study that produced incidence figures for 15 rare epilepsies (e.g. infantile epileptic spasms syndrome 1 in 2,920 live births; Lennox-Gastaut 1 in 9,690; Rasmussen 1 in 450,000) — explicitly could not estimate r(20) because data were limited. That's the strongest available statement that no incidence estimate exists.
Suggested Prevalence record: measure_type: CASES_IN_LITERATURE, prevalence_class: ULTRA_RARE, notes: "<200 individuals reported since 1972; incidence and prevalence unknown."

Inheritance

Almost always de novo / sporadic. MedlinePlus: "Ring chromosome 20 syndrome is almost never inherited."
Rare vertical transmission exists — and it's mosaic-mother → mosaic-child. Peron 2020: four familial cases, "In all the families a mosaic mother transmitted r(20) to the offspring in a mosaic state," and offspring "showed higher r(20) percentages and earlier seizure onset than affected mothers." Primary source: Herrgård E, Mononen T, Mervaala E, Kuusela L, Äikiä M, Stenbäck U, et al. Epilepsy Res 2007;73(1):122–8 (PMID not verified here).
Inheritance term: this is a chromosomal/somatic-mosaic entity. HPO mode-of-inheritance options to consider: HP:0001426 Multifactorial inheritance is wrong; HP:0001470/sporadic framing is better — use HP:0003745 Genetic anticipation? no. The cleanest is HP:0001470 (verify) — honestly, for this entry I'd curate Somatic mosaicism (HP:0001442, verify label with OAK) plus a description noting de novo occurrence, rather than forcing a Mendelian mode. Verify both IDs before writing.
Penetrance: effectively complete for epilepsy in non-mosaic cases (patient-org materials report seizures in ~100% of non-mosaic patients); variable and mosaicism-dependent in mosaic cases — very low ring percentages may be minimally symptomatic.
Expressivity: highly variable; the strongest single determinant is mosaicism level.
Genetic anticipation: the mother→offspring reports show earlier onset and higher ring percentage in offspring — this looks like anticipation but is a mosaicism-dosage effect, not repeat expansion. Curate it as such; don't tag it anticipation.
Germline mosaicism: the transmitting mothers are themselves somatic mosaics; parental karyotype should be considered when counseling. Khamis 2026 recommends genetic counseling referral for all families (quality of evidence "low" due to lack of ring-20-specific data).
Founder effects / carrier frequency / consanguinity: not applicable.

Population demographics

Sex ratio: female excess, and it's specifically in the mosaic group. Peron 2020: mosaic cases 64% F vs 36% M, p<0.0001; non-mosaic 11 M vs 7 F (of 18 with known sex). Tokumoto 2025: 64% female. This female skew in mosaic r(20) is unexplained and would make a decent KNOWLEDGE_GAP.
Ethnicity / geography: no population clustering; cases reported worldwide (Japan, Italy, UK, US, France, Tunisia, China, India, Turkey, Spain, Belgium, Canada). Apparent geographic clustering reflects where dedicated epilepsy centers still karyotype, not real prevalence variation.
Age distribution: pediatric-onset with a growing adult population; the 47-case cohort's psychosocial arm was 30 adults. Adult care is repeatedly flagged as under-served.

10. Diagnostics

10.1 The diagnostic bottleneck — say this loudly

Khamis 2026 (verbatim):

"Ring 20 is likely underdiagnosed, as identification of ring chromosomes often requires a conventional karyotype, a test that is less commonly performed since the advent of readily available next-generation DNA sequencing. In patients with complete ring chromosomes (i.e., no deleted genetic material), chromosomal microarray, gene panels, and whole exome/genome sequencing may all be normal."

This is the inversion of the usual modern workflow — the newest, most expensive tests are the least likely to make this diagnosis. Hirose 2015 (PMID:25957205) makes the same plea: "we emphasize the importance of early G-banding chromosomal analysis when patients present with unexplainable severe seizures and repetitive NCSE, even in the absence of any dysmorphic features suggestive of a chromosomal disorder."

10.2 Genetic testing

Modality	Utility in r(20)	NCIT
Conventional karyotype (G-banding)	GOLD STANDARD. Peron 2020: "Conventional karyotype is a cost-effective and fast test" and "At least 100 metaphases should be analyzed in order not to miss the diagnosis" because of low-level mosaicism	`NCIT:C16768` Karyotyping
FISH (subtelomeric, CHRNA4/KCNQ2 probes)	Adjunct — defines deletion status, quantifies interphase mosaicism (monosomy/duplicated ring); PMID:17851150	—
Chromosomal microarray (CMA)	Normal in complete rings. Useful only to size terminal deletions in the non-mosaic subset	—
Gene panel / WES / WGS	May be entirely normal. Do not rely on it	—
Long-read / optical genome mapping	Not established for r(20) in the literature reviewed — plausible future route, don't assert utility
mtDNA testing, repeat expansion testing	Not applicable

Note: NCIT:C168918 "Number of Cells in Metaphase during Karyotyping" exists and is a genuinely apt data element for the ≥100-metaphase rule if you want to encode it.

10.3 Electrophysiology — the diagnostic workhorse

EEG (NCIT:C38054 Electroencephalography): - Interictal: Peron 2020 — "mild slowing or bursts of sharply contoured theta activity, with a peak frequency of 5 Hz, over the fronto-temporal regions." Prolonged runs of bifrontal sharp-and-slow-wave complexes in extended sleep recordings are considered near-pathognomonic. - Ictal (NCSE): Inoue 1997 (PMID:9217679) — "long-lasting bilateral paroxysmal high-voltage slow waves with occasional spikes"; frontally predominant. Peron 2020 adds: "Repetitive spikes occurred in both frontal regions, followed by 3–4-Hz slow waves and spike-and-wave complexes" with gradual loss of the spike component. - Quantitative signature: reproducible 3–7 Hz "mu-like" sensorimotor rhythm (PMID:23968845). - HPO: HP:0002353 EEG abnormality; HP:0012015 EEG with frontal focal spikes; HP:0012010 EEG with frontal focal spike waves; HP:0033716 EEG with frontal epileptiform discharges; HP:0011290 EEG with frontal sharp slow waves.

Video-EEG is a formal consensus recommendation. Khamis 2026 §3.2.4 (verbatim): "The signs and symptoms of NCSE include drowsiness, moodiness, or feeling unwell. This may not be recognized as a seizure or may be mistaken for a side effect of medication. For any unusual events, video-EEG monitoring should be considered… The EEG findings of NCSE in patients with ring 20 may still be prominent, even after clinical symptoms have lessened."

Electroclinical triad (Gago-Veiga et al., cited in Peron 2020): drug-resistant frontal lobe seizures + recurrent NCSE + typical EEG, reported with 100% sensitivity and negative predictive value. Worth curating as a definitions[] entry with definition_type: DIAGNOSTIC_CRITERIA and derivation_basis: ESTABLISHED_CRITERIA, but check whether that sensitivity figure survives verification — a 100% claim from a small series deserves scrutiny.

10.4 Imaging

Conventional brain MRI: typically normal (Peron 2020). A normal MRI should increase not decrease suspicion in the right electroclinical context.
Research/functional: [¹⁸F]F-DOPA PET (striatal uptake reduction, PMID:15249613), SPECT, EEG-fMRI (nigrostriatal ictal BOLD, PMID:22738216). Not diagnostic; mechanistically informative.

10.5 Laboratory / biomarkers

No blood, urine, CSF, or metabolic biomarker exists. Metabolic workup is unrevealing. Khamis 2026 explicitly lists disease biomarkers as a missing research deliverable.
No biopsy or histopathology role (no characteristic neuropathology).

10.6 Differential diagnosis (from Peron 2020 unless noted)

Differential	Distinguishing feature
Cryptogenic frontal lobe epilepsy	shares semiology; lacks recurrent NCSE and the typical r(20) EEG
Lennox-Gastaut syndrome	similar nocturnal tonic seizures; different semiology and EEG — video-EEG essential
ADNFLE (CHRNA4)	medication typically effective in ADNFLE
Rolandic epilepsy treated with Na⁺-channel blockers	can cause waking NCSE; EEG differs
Anti-NMDAR / autoimmune encephalitis	shares epilepsy + cognitive impairment + psychosis + speech dysfunction; different EEG, plus antibodies and time course
Primary psychiatric disorder (childhood-onset schizophrenia, bipolar I, MDD), narcolepsy	EEG normal in those; hallucinations accompanied by other psychiatric features. This is the most common real-world misdiagnosis — see PMID:41210661
Phelan-McDermid syndrome (22q13.3del)	mild dysmorphism present; seizures benign course
Ring chromosome 14	ID + behavior + drug-resistant epilepsy, but onset in first months/years, distinctive facies (epicanthic folds, downslanting fissures, flat nasal bridge, upturned nares, large low-set ears) and ocular manifestations never seen in r(20)

10.7 Screening

No newborn screening, no carrier screening — and neither would work: the lesion is de novo and mosaic.
Cascade testing only in the rare familial (mosaic mother) scenario.
Prenatal karyotype/CVS can detect a ring, but interpreting a mosaic r(20) prenatally is genuinely hard (mosaicism level in amniocytes ≠ brain).

11. Outcome / Prognosis

Survival and mortality

No survival statistics exist. The largest cohort (n=47, PMID:40119828) reported no fatalities.
SUDEP and status epilepticus are the recognized mortality risks; SUDEP counseling is an explicit consensus recommendation (Khamis 2026 §3.2.3). A refractory-and-lethal status epilepticus case is on record (Jacobs J, Bernard G, Andermann E, Dubeau F, Andermann F. Epileptic Disord 2008;10(4):254–9).
Life expectancy is not established. Do not assert a number.

Morbidity and function

Intellectual disability in 57.4% (n=47) with mean IQ 66.4 ± 16.0; ASD 17.0%; psychiatric symptoms 21.3% (PMID:40119828).
Adult functional outcomes (n=30): employed 23.3%, married 6.7%, driving 3.3%, living with family 83.3%.
No r(20)-specific QoL instrument or published EQ-5D/SF-36/PROMIS data. Gordon 2020 (PMID:32524055) calls for exactly this: "A health economic analysis illustrating reduced acute care costs or improved quality of life may support more widespread KDT implementation."

Disease course and complications

Drug-resistant epilepsy in ~80%; recurrent NCSE with cumulative cognitive cost; behavioral deterioration; caregiver burden.
Peron 2020 identifies two trajectories: "a group with favorable outcome (no seizures, with or without medications), and a group with unfavorable course (refractory epilepsy with focal seizures and NCSE)."

Prognostic factors (this is the actionable bit)

Age at seizure onset — later onset → better outcome (Peron 2020: "The main determinant of the outcome is the age at seizure onset"; Vignoli 2016).
Ring mosaicism percentage — inversely correlated with age at onset; higher mosaicism → earlier onset, more severe cognitive impairment (Peron 2020; Hirose 2015; Brenton 2026).
Mosaic vs non-mosaic status — non-mosaic is earlier and more severe (Conlin 2011).
Treatment factor: Tokumoto 2025 multivariate analysis — "lower mosaicism rate and higher rate of lamotrigine use as independent factors associated with favorable seizure outcome."
Degree of seizure control is the proximate predictor of cognitive/behavioral trajectory (patient-organization consensus).

No prognostic biomarker exists.

12. Treatment

Big honest caveat first, straight from the consensus (verbatim): "Our review found that there are very few high-quality data available to guide treatment in ring 20. The majority of publications are individual case reports or small case series." And: "The current evidence is insufficient to strongly recommend any particular medications."

12.1 The eight consensus recommendations (Khamis et al. 2026, PMID:42096279 — verbatim from the abstract)

"The care team should be multidisciplinary and include at least an epileptologist and allied health specialists (e.g., speech therapist, occupational therapist, physiotherapist, psychologist)"
"patients and families should be referred for genetic counseling"
"if patients are diagnosed with epilepsy, they and their families should be counseled that seizures are likely to be drug-resistant and life-long"
"as there is a high incidence of non-convulsive status epilepticus (NCSE), there should be a low threshold for video-EEG monitoring if patients have a change in behavior or level of consciousness"
"initial epilepsy treatment should be with an oral anti-seizure medication"
"home rescue medication should be considered given the risk for prolonged seizures and NCSE"
"for patients with drug-resistant epilepsy, ketogenic diet, vagus nerve stimulation, or deep brain stimulation could all be considered"
"caregiver burnout and stress should be screened for and supports provided"

Overarching principle (verbatim, §3.2.5): "management should always be aimed at optimizing quality of life, rather than controlling seizures at all costs. In particular, efforts should be made to minimize polypharmacy and avoid exposing patients to medication side effects unnecessarily."

12.2 Pharmacotherapy

First-line (consensus): valproic acid, lamotrigine, and other sodium channel antagonists (quality of evidence "low"). Combination lamotrigine + valproate "has worked well in some patients."

Evidence base: - Tokumoto 2025 (n=47): among the ~30% who were drug-responsive, lamotrigine effective in 69%, valproic acid in 43%. - Vignoli 2016 cohort (24 with r(20) + epilepsy): LTG+VPA combination improved seizure control in 8 patients. - Peron 2020: "In our experience, valproic acid and lamotrigine, often in combination, are generally the most effective antiepileptic drugs (AEDs) for treating seizures in r(20)."

Agents with positive individual reports (case-report level only — Khamis 2026 §3.1.1): lacosamide (Tayama 2020; Onder & Tezer 2016), zonisamide (Parravicini 2023), ezogabine/retigabine (Walleigh 2013 — framed as "a pediatric potassium channelopathy responsive to treatment with ezogabine"), felbamate (García-Cruz 2000), perampanel (Ling 2022), gabapentin.

Agents reported as less likely to help: primidone, ethosuximide, clobazam. Khamis 2026 is careful here: "data for or against use of specific agents based solely on individual case reports is of very limited clinical utility."

Watch-outs: - Levetiracetam can exacerbate behavioral issues (Khamis 2026, §3.1.7) — a real concern given the behavioral phenotype. - Perampanel worsened aggression and produced new seizure types in one 42-year-old; NCSE frequency fell after switching to lacosamide (PMID:41210661). So perampanel appears in both the "helped" and "harmed" columns — curate both.

Other pharmacologic: - Corticosteroids: 8 reported patients, 1 (12.5%) with significant benefit — an 11-year-old on monthly IV methylprednisolone went from 20–40 seizures/day to 2–3/week with concurrent cognitive and functional improvement (Kishore 2022); the rest little or no response. - Lithium: 1 patient, "marked improvement in behavior and psychiatric symptoms, as well as >95% reduction in seizure frequency" — a 12-year-old with r(20), DRE and bipolar disorder NOS (Inal et al. 2018, PMID:30455928). - Cannabidiol: essentially no r(20)-specific data. One r(20) patient was included in a real-world CBD add-on study (Vicino et al. 2023, PMID:37506564) with no individual response data reported, other than elevated serum aminotransferases. - IVIg: 1 patient, no benefit. - Melatonin (4 mg/day): single case, associated with REM facilitation and reduced NCSE (PMID:40881175). Hypothesis-generating only.

Rescue medication (consensus, quality "low"): rectal diazepam, intranasal/buccal midazolam, or sublingual lorazepam, with a written individual care plan for status epilepticus including NCSE. Nuance worth preserving: "Some clinicians may recommend earlier home medication for convulsive seizures (e.g., 5 min) than NCSE (e.g., 30 min), particularly if patients tend to require long recovery times from the rescue medication."

Pharmacogenomics: nothing r(20)-specific. Standard HLA-B15:02/carbamazepine and UGT/lamotrigine-rash* considerations apply generically.

CHEBI IDs (all OAK-verified): lamotrigine CHEBI:6367 · valproic acid CHEBI:39867 · lacosamide CHEBI:135939 · perampanel CHEBI:71013 · zonisamide CHEBI:10127 · ezogabine CHEBI:68584 · felbamate CHEBI:4995 · levetiracetam CHEBI:6437 · clobazam CHEBI:31413 · cannabidiol CHEBI:69478 · lithium carbonate CHEBI:6504 · midazolam CHEBI:6931 · melatonin CHEBI:16796. (Note: CHEBI:6888 is 6alpha-methylprednisolone, not plain "methylprednisolone" — pick your term deliberately if you curate the steroid arm.)

NCIT treatment terms (OAK-verified): NCIT:C15986 Pharmacotherapy · NCIT:C64172 Anticonvulsant Therapy · NCIT:C264 Anticonvulsant Agent · NCIT:C15447 Dietary Intervention · NCIT:C173168 Ketogenic Diet · NCIT:C21024 Deep Brain Stimulation · NCIT:C15240 Genetic Counseling · NCIT:C38054 Electroencephalography · NCIT:C16768 Karyotyping. Heads up: I could not find an NCIT term for implanted vagus nerve stimulation. NCIT has NCIT:C203750 Transcutaneous Auricular Vagus Nerve Stimulation (wrong modality) and NCIT:C21025 Peripheral Nerve Stimulation (parent, imprecise). Use the parent with a specific preferred_term, or omit term: — don't force the transcutaneous term.

12.3 Non-pharmacological

Ketogenic dietary therapy (NCIT:C173168, therapeutic_modality: BEHAVIORAL): - Gordon D, Watson A, Desurkar A, Cowley L, Hiemstra TF. Assessing the role of ketogenic dietary therapy in ring chromosome 20 syndrome: A patient-led approach. PMID:32524055, Epilepsia Open 2020;5(2):295–300. 42 patients/families/carers + 23 healthcare professionals surveyed. Of 20 who tried KD: 6 reported significant improvement, 3 mild; per Khamis's tabulation, "improvement in seizures in 30% and cognition and alertness in 30%." One report of increased seizure frequency. Side effects otherwise typically mild. - Counter-evidence: Tokumoto reported 3 r(20) patients on KD and 1 on modified Atkins — none reported positive effects. - Practical barriers specific to r(20): older age at presentation, comorbid ADHD/autism/severe cognitive impairment, and — in the UK — NHS KDT services being predominantly pediatric with "very limited adult access."

Vagus nerve stimulation: - Lajoie C, Hrazdil C, Riou É, Myers KA. Response to vagus nerve stimulation in people with ring chromosome 20. PMID:40876406, Seizure 2025;132:13–9. 11/14 (79%) reported some improvement: seizure frequency reduction (5), shorter seizure duration (3), reduced/eliminated NCSE or specific seizure types (3), reduced rescue medication (2), shorter post-ictal symptoms (2), improved cognition (2), reduced aggression (1). - Dramatic outlier: a 6-year-old girl resistant to 10 ASMs, IV methylprednisolone and KD became seizure-free after VNS implantation and titration, with greater alertness and speech onset having been previously nonverbal (Chawla et al. 2002). - But mixed overall across the older case-report literature; many patients had no or marginal benefit. Also relevant: Hajtovic S, LoPresti MA, Zhang L, et al. PMID:35303699, J Neurosurg Pediatr 2022 — VNS meta-analysis in genetic etiologies of DRE.

Deep brain stimulation (NCIT:C21024): only 3 reported r(20) patients — 1 improved, 1 no change, 1 worsened (DBS subsequently deactivated). Centromedian nucleus targeting in a 43-year-old produced no significant improvement (Arévalo-Sáenz 2015). Consensus still lists DBS as considerable for DRE, on general-epilepsy evidence (>50% seizure reduction in 75% of 72 children in a systematic review) rather than r(20) data.

Responsive neurostimulation: 1 patient, implanted too recently to judge. Khamis: "a potentially good candidate intervention (quality of evidence 'very low')… there are currently no data regarding effectiveness."

Corpus callosotomy: 4 patients — 2 no benefit, 1 significant seizure improvement, 1 less severe seizures without frequency change. Consensus: "could be considered as a palliative procedure in patients with frequent, highly problematic tonic or atonic seizures."

Resective surgery: explicitly NOT recommended. Khamis 2026 (verbatim): "Surgical resection is not recommended, as such interventions are very unlikely to be effective and could have significant complications (quality of evidence 'low')." The reported experience is 4 patients across 3 studies, "overall ineffective. No patients had sustained clinical benefit," including a patient who had two right parietal resections before the genetic diagnosis was made. This makes biological sense — the pathology is a bilateral network, not a focus.

12.4 Rehabilitative / supportive

Speech therapy (NCIT:C159273), physiotherapy (NCIT:C15302), occupational therapy (NCIT:C121351), neuropsychological evaluation for school-age children to guide educational placement, psychology/psychiatry involvement for behavioral issues, and a planned pediatric→adult transition beginning in early adolescence (all quality of evidence "low" due to lack of ring-20-specific data). Verify those three NCIT IDs against OAK — I checked C15302, C15240, C15447, C15986 but not C159273/C121351.

12.5 Experimental / trials

None. Zero registered r(20) interventional trials; zero randomized or open-label prospective studies in the literature. Curate clinical_trials: as empty rather than stretching for a tangential trial.

12.6 Treatment algorithm (as consensus describes it)

Oral ASM (VPA / LTG / Na⁺-channel agent) → if uncontrolled, second ASM, consider LTG+VPA combination → after failure of 2 ASMs, discuss non-pharmacologic options (KD, VNS, DBS) → home rescue medication + written status-epilepticus care plan throughout → callosotomy only as palliation for tonic/atonic seizures → not resection. Concurrent: multidisciplinary comorbidity management, caregiver support, transition planning.

13. Prevention

Primary prevention: none possible. The lesion is a de novo post-zygotic/gametic event with no known modifiable cause. Say this plainly rather than leaving the section blank.
Secondary prevention (early detection) — this is where the real opportunity is. The intervention isn't preventing r(20); it's preventing the diagnostic delay. The actionable rule: karyotype (≥100 metaphases) any child with unexplained drug-resistant focal epilepsy, recurrent NCSE, and cognitive/behavioral regression — even with normal facies, normal growth, normal MRI, and a normal exome. Early diagnosis prevents futile resective surgery (documented to have happened), prevents years of psychiatric misdiagnosis (documented, PMID:41210661), and enables early non-pharmacologic therapy while cognition is preserved (Gordon 2020).
Tertiary prevention: NCSE recognition and home rescue protocols; SUDEP counseling and nocturnal supervision/monitoring discussion; minimizing polypharmacy and avoiding behaviorally-aggravating agents; caregiver burnout screening.
Genetic counseling (NCIT:C15240): consensus-recommended for all families. Content should cover mosaicism, prognosis, and inheritance risk to other family members. Recurrence risk is low but not zero — the mosaic-mother transmissions mean parental karyotype should be considered, and prenatal diagnosis is technically possible where a parent is mosaic.
Immunization / public health / environmental / behavioral prevention: not applicable.

14. Other Species / Natural Disease

Taxonomy: Homo sapiens, NCBITaxon:9606. No naturally occurring animal counterpart of r(20) has been identified in this review — I found no OMIA entry, no veterinary case series, no breed association (so no VBO term).
Orthology: human chromosome 20 is syntenic largely with mouse chromosome 2 (plus segments of Mmu 6). But synteny doesn't help here — the disease entity is the ring topology of a specific human chromosome, which has no orthologous structure. CHRNA4 and KCNQ2 have mouse orthologs (Chrna4, Kcnq2) with well-characterized epilepsy phenotypes, but those model the candidate-gene hypothesis, not r(20).
Comparative biology: ring chromosomes as a class occur across eukaryotes and behave the same way everywhere — mitotic instability, sister-chromatid-exchange-driven interlocking/dicentric formation, anaphase bridges, ring loss. This is McClintock's breakage–fusion–bridge biology, and it is deeply evolutionarily conserved. That conservation is a real asset for studying ring instability; it is not a model of the r(20) phenotype.
Zoonotic potential / cross-species transmission: not applicable.

15. Model Organisms

Short version: there aren't any, and that's a named research priority.

No mouse, rat, zebrafish, fly, or worm model of ring chromosome 20 exists. You cannot knock in a human ring chromosome, and no engineered rodent ring-2 model has been reported as an r(20) surrogate.
iPSC models are blocked by an elegant biological problem. Peron 2020 lays out the aspiration — iPSC-derived neuronal progenitors retaining a structurally complete ring, used to map its nuclear position and 3D folding — and then the obstacle: "the RC is lost early after reprogramming and before any iPSC-induced differentiation." This connects to a landmark finding: Bershteyn M, et al. Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. PMID:24413397, Nature 2014;507:99–103. iPSCs derived from ring-chromosome patient fibroblasts spontaneously lose the ring and duplicate the wild-type homolog via compensatory uniparental disomy, and the karyotypically normal isodisomic cells outgrow the aneuploid population. Framed there as a route to "chromosome therapy" — but for r(20) modeling it's a curse: the dish cures the cell you were trying to study. See also Sci Rep 2021;11:s41598-021-83399-3, "Complex biology of constitutional ring chromosomes structure and (in)stability revealed by somatic cell reprogramming," and PMID:27882407 for the correction-via-reprogramming framework. → This is a textbook HUMAN_MODEL_MISMATCH discussion: evidence can be generated in a model system, but the model system systematically eliminates the lesion.
Available human material: patient lymphocytes/fibroblasts (retain the ring; support cytogenetics and the Myers 2021 RNA-seq design), and first-degree-relative controls.
Explicit call in the literature — Khamis 2026 (verbatim): "The development of in vivo and in vitro models, as well as disease biomarkers, is essential for the discovery and evaluation of novel, targeted therapies."
Model databases: MGI/RGD/ZFIN/IMSR contain no r(20) model. Chrna4 and Kcnq2 mouse alleles exist in MGI and are appropriate only for the candidate-gene arm, with the caveat that the deletion hypothesis is largely refuted for r(20) generally.

Curation notes for the dismech entry

Model the mechanism as unresolved. Use mechanistic_hypotheses with stable group IDs — something like subtelomeric_haploinsufficiency (status: ALTERNATIVE / partially refuted, applies to the non-mosaic deleted subset), telomere_position_effect (status: ALTERNATIVE, directly tested and unsupported), ring_instability_dynamic_mosaicism (CANONICAL-ish / EMERGING), complex_polygenic_dysregulation (EMERGING). Attach the Myers 2021 refutation to the TPE group explicitly — a curated negative result is worth more here than a confident causal chain.
The epilepsy_excitation_inhibition_imbalance module is the natural conformance target — key node epilepsy_excitation_inhibition_imbalance#Excitation-Inhibition Imbalance. But keep the nigrostriatal seizure-termination failure as an r(20)-specific node; that's a distinct claim from ictogenesis and it's what makes this syndrome mechanistically interesting.
Two subtypes are well supported and cleanly foreign-keyable: Mosaic and Non-mosaic, differing in formation mechanism, deletion status, onset age (6.0 vs 2.1 y), severity, sex ratio, and dysmorphism. Conlin 2011 (PMID:20972251) is the anchor citation for both.
Frequency bands: the 192-patient systematic review (PMID:42468067) gives clean numerators for NCSE (88%), ictal fear (72%), FIAS (50.3%), drug resistance (80%). Those support real FrequencyEnum values. Everything softer — "behavioral problems," "cognitive decline" — should probably go without a frequency: rather than be bent to fit a band.
KNOWLEDGE_GAP candidates: (a) mechanism linking complete ring to epilepsy; (b) unexplained female excess in mosaic r(20) (p<0.0001); (c) absence of any incidence/prevalence estimate, with PMID:38795333 as the citation showing a well-powered population study explicitly couldn't produce one; (d) no biomarker; (e) no disease model.
Do not cite an OMIM number — there isn't one. And treat the MONDO definition's "macrocephaly" as unsupported by the primary literature.

Ask OpenScientist

OpenScientist Report

Mappings

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Medical Actions

Diagnosis

Progression

Prevalence

Differential Diagnoses

Source YAML

References & Deep Research

References

Deep Research

Ring Chromosome 20 Syndrome — Disease Characteristics Research Report

0. Executive framing

1. Disease Information

Overview

Key identifiers

Synonyms

Data provenance

2. Etiology

2.1 Causal factor — the ring itself

2.2 Genetic risk factors

2.3 Environmental risk factors

2.4 Protective factors

2.5 Gene–environment interactions

3. Phenotypes

3.1 Core electroclinical phenotype

3.2 Seizure semiology (three recurring types, per Peron 2020)

3.3 Non-convulsive status epilepticus — the signature

3.4 Ictal fear and hallucinations

3.5 Cognitive and behavioral phenotype

3.6 Physical phenotype (mostly absent — this is diagnostically load-bearing)

3.7 Age-dependent phenotype gradient

3.8 Quality of life

4. Genetic / Molecular Information

4.1 Causal lesion

4.2 Candidate genes (only relevant to the deleted subset)

4.3 Epigenetics

4.4 Transcriptomics — the key negative result

4.5 Chromosomal instability / dynamic mosaicism

5. Environmental Information

6. Mechanism / Pathophysiology

6.1 The central paradox

6.2 Competing mechanistic hypotheses

6.3 The downstream network finding — basal ganglia / nigrostriatal seizure-control failure

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

Epidemiology

Inheritance

Population demographics

10. Diagnostics

10.1 The diagnostic bottleneck — say this loudly

10.2 Genetic testing

10.3 Electrophysiology — the diagnostic workhorse

10.4 Imaging

10.5 Laboratory / biomarkers

10.6 Differential diagnosis (from Peron 2020 unless noted)

10.7 Screening

11. Outcome / Prognosis

Survival and mortality

Morbidity and function

Disease course and complications

Prognostic factors (this is the actionable bit)

12. Treatment

12.1 The eight consensus recommendations (Khamis et al. 2026, PMID:42096279 — verbatim from the abstract)

12.2 Pharmacotherapy

12.3 Non-pharmacological

12.4 Rehabilitative / supportive

12.5 Experimental / trials

12.6 Treatment algorithm (as consensus describes it)

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Curation notes for the dismech entry